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Chapter 1: Introduction 
Medicare Part D is the single most important extension to Medicare since the program’s 
inception.  Medicare Part D, which took effect in January 2006, makes prescription drug 
insurance available to all beneficiaries at a reasonable premium.  Under Part D every beneficiary 
can purchase a drug insurance plan from a range of plans offered by private health insurers, with 
premium subsidies available to persons with low income and few resources.  
Prior to Part D many seniors found paying for prescribed medications to be a challenge 
(Madden, Graves, Zhang, et al. 2008; Mott, Thorpe, Thorpe, et al. 2010).  African-Americans 
and Hispanics were particularly vulnerable to experiencing difficulties paying for prescription 
drugs (Gellad, Haas, and Safran 2007).  In 2003, 25% of African-American and Hispanic 
seniors, compared to 11% of White seniors, reported spending less on food and other basic needs 
in order to pay for prescription drugs (Gellad et al. 2007).    
A lack of drug insurance has been found to correlate with reducing or skipping doses of 
prescribed medications as a way to cope with the cost of the drugs (Balkrishnan 1998; Soumerai, 
Pierre-Jacques, Zhang, et al. 2006).  Not surprisingly, such behavior, called cost-related 
medication non-adherence (CRN), has been shown to raise the risk of adverse health events 
(Heisler, Langa, Eby, et al. 2004; Sokol, McGuigan, Verbrugge, et al. 2005; Jensen and Li 2012).     
Reducing racial and ethnic health disparities has been a national policy goal for some time 
(AHRQ 2007; DHHS 2010).  Because Part D makes drug insurance available to all beneficiaries, 
and because it provides substantial premium subsidies for many low-income beneficiaries, it has 
the potential to significantly reduce disparities in beneficiaries’ access to drug insurance, in 
prescription drug utilization and spending, and in utilization of hospitals and emergency 
departments. 
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To the author’s knowledge, no studies have examined whether Medicare Part D has 
reduced racial/ethnic disparities in these areas.  This dissertation seeks to fill this void by 
evaluating the effects of Part D on racial/ethnic disparities, using the Institute of Medicine (IOM) 
definition of a disparity.  Using data from the 2002-2009 Medical Expenditure Panel Survey 
(MEPS), this study employs a difference-in-differences methodology to isolate the effects of Part 
D, comparing changes in racial/ethnic disparities among Medicare seniors that occurred 
following the introduction of Part D to changes in racial/ethnic disparities among adults without 
Medicare, ages 55-63, over the same period. 
The remainder of this dissertation proceeds as follows:  Section 2 evaluates the effects of 
Medicare Part D on racial/ethnic disparities in utilization of and spending in prescription drugs.  
Part 3 evaluates the effects of Part D on racial/ethnic disparities in utilization of medical services 
and in total health care cost.  Section 4 analyzes the effect of Part D on racial/ethnic disparities 
discussed in sections 2 and 3, using two alternative definitions of a disparity.  Finally Section 5 
concludes this dissertation.   
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Chapter 2: Medicare Part D and Racial/Ethnic Disparities in Utilization 
and  Spending 
 
In this chapter I examine racial/ethnic disparities in five measures: 1) prevalence rate of 
drug coverage, 2) prevalence of any prescription drug use, 3) annual number of positive 
prescription drugs filled/refilled, 4) positive annual total prescription drug expenditure, and 5) 
positive annual out-of-pocket prescription drug expenditure. 
2.1  Background 
Medicare Part D, enacted as part of the Medicare Modernization Act of 2003, took effect 
January 1, 2006.  Beneficiaries who choose to enroll in Part D select a prescription drug plan and 
pay a premium for their coverage.  Beneficiaries can obtain Part D coverage through two types 
of private-sector plans: prescription drug plans (PDPs), which only cover drugs, and Medicare 
Advantage plans with prescription drugs (MAPDs), which cover both medical services and 
drugs.  Alternatively, they can continue with whatever drug insurance they held prior to 2006, 
provided that plan has benefits at least as generous as the Medicare-set “standard PDP benefits.”  
Besides making drug coverage available to all beneficiaries, Part D provides premium subsidies 
for beneficiaries with limited income and resources through its “Low-Income Subsidy (LIS) 
Program.”  To receive an LIS a beneficiary must apply to the Social Security Administration 
(SSA) and be deemed to qualify.  However, individuals who have both Medicare and Medicaid 
(called “dual eligibles”) do not need to apply, as they are automatically enrolled in the LIS 
program.   
Many studies have investigated the effects of Part D on the take-up of drug insurance, and 
on prescription drug utilization and spending (Lichtenberg and Sun 2007; Levy and Weir 2009; 
Mott et al. 2010; Engelhardt and Gruber 2011).  Using data from one of the national pharmacy 
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chains, Lichtenberg and Sun (2007) found an 18% reduction in beneficiaries’ prescription drug 
out-of-pocket spending and a 4.5% increase in prescription utilization as a result of Part D.  
Using data from the Health and Retirement Study, Levy and Weir (2009) examined the take-up 
of Part D coverage and the LIS program.  They found that how a beneficiary was affected 
depended on their prior source of coverage.  Take-up among beneficiaries without any prior 
coverage was high.  LIS enrollment, however, has been low, mainly because many eligible 
beneficiaries are unaware of this program or unsure of their eligibility for it.  Using data from the 
2002-2006 MEPS, Engelhardt and Gruber (2011) estimate that Part D has “crowded-out” 75% of 
the drug insurance arrangements already in place before the program began, which they argue 
reduces the expected welfare gains from the program.   
Racial/ethnic disparities related to prescription drugs have not been as widely studied as 
disparities in other areas.  Briesacher et al. (2004) compared the prevalence of drug coverage and 
prescription drug utilization by race and ethnicity among Medicare beneficiaries with chronic 
conditions using data from the 1999 Medicare Current Beneficiaries Survey (MCBS).  Among 
beneficiaries without any drug coverage, they found that African-Americans and Hispanics used 
10-40% percent fewer medications than Whites, and overall they spent up to 60% less on their 
medications.  Gaskin et al. (2006) examined racial/ethnic disparities in drug utilization and 
spending, also using the 1999 MCBS.  They found that, compared to minorities, Whites used 
more medications and had higher out-of-pocket spending and total spending on drugs.   
Earlier research showed that during the 1990s racial/ethnic disparities in the prevalence of 
drug insurance diminished among Medicare beneficiaries (Briesacher, Stuart, and Shea 2002).  
From 1993 to 1998 the percentage of Medicare beneficiaries with some type of drug coverage 
increased from 65 to 76% (Briesacher et al. 2002), in part because of the growth of Medicare 
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Advantage (MA) plans.  Prior to Part D, most MA plans contained drug coverage (Levy et al. 
2009).  Additionally, before Part D, dual eligibles (about one third of minority seniors) used to 
receive drug coverage through Medicaid.   
Sources of drug coverage tend to vary between Whites and minorities (Gellad et al. 2007; 
Safran, Strollo, Guterman, et al. 2010).  Prior to Part D, relatively more White seniors had drug 
coverage through employer-sponsored plans (Briesacher et al. 2004; Gellad et al. 2007).  
Medicaid and MA plans were the two main sources of drug coverage for Hispanic seniors, and 
Medicaid and employer-sponsored plans were the two main sources of drug coverage for 
African-American seniors (Briesacher et al. 2004).   
Gellad et al. (2007) analyzed data from a 2003 nationwide survey of seniors and found no 
significant racial/ethnic disparities in drug coverage or drug use.  However, they found 
significant racial/ethnic disparities among seniors in their sources of coverage, in their income 
and education, and in CRN.  They found that among seniors who reported any medication non-
adherence, 40 percent of African-Americans and Hispanics compared to 28 percent of Whites 
reported cost as their reason for non-adherence.  Madden et al. (2008) found that Part D 
significantly reduced the odds of CRN, as well as spending less on basic needs as a means for 
coping with high out-of-pocket costs.  
A few studies have examined the effects of Part D on specific sub-populations.  Basu, Yin 
and Alexander (2010) examined the impact of Part D on dual eligibles, and did not find any 
significant effects on the number of prescriptions filled, out-of-pocket spending, or total 
spending, which suggests that dual eligibles made a smooth transition from receiving their drug 
coverage under Medicaid to receiving it under Part D.  Liu and colleagues (2011) investigated 
6 
 
 
the effects of the program among non-low income beneficiaries and found significant increases 
in drug utilization and a significant reduction in out-of-pocket spending.     
This study is also concerned with the program’s effects on specific subpopulations, namely 
those defined by race and ethnicity, and in particular, its effects on racial/ethnic disparities 
related to prescription drugs.  
2.2   Data and Methods 
Data 
This study uses the Household Component (HC) files of the 2002-2009 MEPS.  MEPS is 
an ongoing, nationally representative survey of the U.S. civilian, non-institutionalized 
population, conducted annually by the Agency for Healthcare Research and Quality (AHRQ) 
(Cohen, Monheit, Beauregard, et al. 1997).  This dissertation focuses on Medicare beneficiaries, 
ages 65 and older, as the “treatment” group, and adults, ages 55 to 63, who are not Medicare 
eligible, as the “comparison” group.  In both groups the study limits the attention to individuals 
who self-report being (non-Hispanic) African-American, Hispanic, or (non-Hispanic) White, 
based on MEPS questions regarding race and ethnicity.  Other minority groups are not examined 
due to their small sample counts in MEPS.   
The main analytic sample includes 36,902 MEPS respondents, 20,821 of whom are in the 
treatment group and 16,081 of whom are in the comparison group.  In the treatment group there 
are 10,943 individuals (Whites=8,262, African-Americans=1,307, Hispanics=1,374) who were 
surveyed between 2002 and 2005 and 9,878 individuals (Whites=7,004, African-
Americans=1,550, and Hispanics=1,324) who were surveyed between 2006 and 2009, whereas 
in the comparison group there are 7,879 individuals (Whites=5,663, African-Americans=1,003, 
Hispanics=1,213) who were surveyed between 2002 and 2005 and 8,202 individuals 
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(Whites=5,376, African-Americans=1,383, Hispanics=1,443) who were surveyed between 2006 
and 2009.
1
   
Throughout, this study adjusts for the clustered and stratified survey design of MEPS, and 
weights all estimates using the AHRQ-supplied weights.  I use SAS 9.3 to carry out all 
descriptive analyses and Stata 11 for regression analyses.  
Dependent and Independent Variables 
In this chapter I examine five dependent variables: (1) whether the individual holds 
prescription drug insurance (from any source), (2) whether any prescriptions are filled during the 
year, (3) the number of prescriptions (including refills) filled during the year, (4) total annual 
spending on prescription drugs, and (5) out-of-pocket annual spending on prescription drugs.   
MEPS has three sources of information for whether an individual holds drug coverage: the 
drug insurance section of the survey, the prescription utilization section, and the prescription 
expenditures section.   In the drug insurance section each individual was asked whether they 
currently hold any drug coverage.  Starting in 2006 a separate question was added for Medicare 
beneficiaries about whether their drug coverage was obtained through Part D.  In the utilization 
and expenditures sections of MEPS, questions were asked regarding each prescription filled 
during the previous round, if any were, and the total and out-of-pocket cost of each prescription.  
With each participant’s consent, MEPS staff verified the detailed prescription information 
reported using actual pharmacy records.  If consent was not granted, the data are the participant’s 
own self-reported information.   
Drug insurance is measured as a dichotomous variable that equals 1 if the drug insurance 
section, the utilization section, or the expenditures section of MEPS reveals the presence of drug 
coverage and 0 otherwise.  Any-prescriptions-filled and the annual number of prescriptions filled 
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are from the utilization section of MEPS, and total and out-of-pocket annual spending on 
prescription drugs are from the expenditures section of MEPS.  Before beginning the analysis 
total and out-of-pocket spending were converted to inflation-adjusted 2007 dollars using the all-
items Consumer Price Index. 
Andersen’s conceptual framework guides the choice of explanatory variables for the 
models to be estimated (Andersen 1968).  Each model includes need-related variables, such as 
age, gender, and measures of health and functioning.  This study also includes predisposing and 
enabling factors such as marital status, education, income, health insurance, health habits, 
attitudes towards risk and insurance, location, and language.  To control for health and 
functioning, this study includes a range of variables.  Two (0,1) indicators for whether self-rated 
health and self-rated mental health, respectively, are fair or poor, as opposed to good or better, 
are included in the models, as well as (0,1) indicators for whether the individual reports any heart 
problems, diabetes, asthma, arthritis, high blood pressure, or having had a stroke.  For physical 
functioning, we include the number of functional limitations reported, and the number of chronic 
conditions reported (summed across 10 distinct conditions).   This study also includes two 
summary indices of overall physical and mental health, specifically, the norm-based physical 
component summary scale (NBPCS) and the norm-based mental component summary scale 
(NBMCS), both calculated from Version 2 of the Short Form 12 Health Survey (SF12-V2) 
(Ware, Kosinski, Turner-Bowker, et al. 2002).  Marital status is measured with a (0,1) indicator 
for whether the individual is currently married.  Education is measured by a series of mutually-
exclusive (0,1) indicators for whether education is less than high school, college degree, graduate 
school degree, or another degree, with high school serving as the reference category.  Household 
income is measured using four mutually-exclusive categories:  poor or near poor (household 
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income is less than 125% of the federal poverty level (FPL)), low income (household income is 
125-199% of FPL), middle income (household income is 200-399% of FPL), and high income 
(household income is at least 400% of FPL), with low income serving as the reference category.  
For health insurance this study includes a (0,1) indicator for whether the individual reports (at 
any time during the past year) having Medicaid, as well as (0,1) indicators describing the nature 
of their private insurance holdings, specifically, whether the individual holds HMO coverage, 
private non-HMO insurance, or has no private insurance, with the last of these serving as the 
reference category.  Health habits are measured by two (0,1) indicators, one for whether the 
individual exercises 2-3 times a week, the other for whether they currently smoke.  Attitudes 
towards insurance are measured by a (0,1) indicator for whether they think they do not need 
health insurance, and a (0,1) indicator for whether they think health insurance is not worth the 
cost.  This study also controls for whether the individual resides in an urban area, and their US 
Census region, with the West as the reference category.  Finally, all models adjust for English 
language fluency, with a (0,1) indicator for whether the individual conducted their MEPS 
interview in English.   
IOM Definition and Measurement of a Disparity 
2
  
This dissertation follows the Institute of Medicine’s (IOM) definition of a racial or ethnic 
disparity.  In its 2002 report, Unequal Treatment: Confronting Racial and Ethnic Disparities in 
Health Care, the IOM defines a disparity as “a difference in access or treatment provided to 
members of different racial or ethnic groups that is not justified by the underlying health 
conditions or treatment preferences of patients.”  McGuire et al. (2006) and Cook et al. (2007) 
describe the methods for implementing this definition, and this dissertation applies their methods 
here.   
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Briefly, this study uses a four-step procedure to calculate disparities.  First, for each 
outcome measure this study fits a multivariate regression using the explanatory variables 
described above that allows for the effects of key explanatory variables to vary by race and 
ethnicity.  Second, the study transforms the distribution of the need-related explanatory variables 
for each minority group to be the same as their distribution among Whites, while leaving the 
non-need-related variables unchanged.  A “rank-and-replace” algorithm is used to make these 
transformations (McGuire et al. 2006), thereby replicating the entire shape of the Whites’ need-
related distributions.  Third, this study uses the fitted regression to calculate predicted values of 
the outcome measure for each minority group member using their transformed values for need-
related variables and their actual values for other variables in the model.  Finally, this study 
averages these predictions by population group, and calculate a disparity in the outcome measure 
as the difference between the average hypothetical value for that outcome in the minority group 
and the average value for that outcome among Whites.  In the treatment group disparities are 
measured before Part D and then after Part D, and the same is done in the comparison group.         
Difference-in-Differences and Regression Framework for Evaluation 
This dissertation uses a difference-in-differences (DD) methodology to estimate Part D’s 
effects on racial/ethnic disparities in drug coverage, prescription utilization, and prescription 
drug spending.  DD methods are valid if, absent Part D, both the treatment and comparison 
groups would have experienced similar trends in racial/ethnic disparities over the period 
(Bertrand, Duflo, and Mullainathan 2004).  This study examines this issue and formally tests for 
trend similarities. 
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The regression equation below illustrates the basic structure of the estimated models before 
calculating IOM disparities.  In this equation Medicare seniors comprise the “treatment group,” 
and adults without Medicare, ages 55-63, comprise the “comparison group”: 
j
K
1i
iji3H3jjjH2jj
H1jjH0jA3jjjA2jj
A1jjA0j3jj2j1j0j
Xˆˆ)PartD*Trt*H(ˆ)H*PartD(
ˆ)Trt*H(ˆHˆ)PartD*Trt*A(ˆ)A*PartD(
ˆ)Trt*A(ˆAˆ)PartD*Trt(ˆPartDˆTrtˆY






 
Here, j indexes an individual and Y is one of the outcome measures, e.g., total annual 
spending on drugs.  “PartD” is a (0,1) indicator for whether the individual was surveyed after 
January, 2006 or before then (1 if after, 0 if before), and “Trt” is a (0,1) indicator for membership 
in the treatment group (1 if yes, 0 if no).  “A” and “H” are (0, 1) indicators for whether the 
individual is African-American or Hispanic, respectively (1 if yes, 0 if no).  Finally, the Xi’s are 
other relevant explanatory variables (described earlier), such as demographic and socio-
economic characteristics, and for some of the Xi’s, their interactions with the race/ethnicity 
indicators.
3
  
For prescription drug coverage and any-prescriptions-filled, this dissertation fits logistic 
regressions (Tables B1-B2 in Appendix).  For the positive number of prescriptions filled and for 
each positive expenditure measure the study fits a generalized linear model (GLM) (McCullagh 
and Nelder 1989).  On the basis of a modified Park test (Park 1966) and other recommended 
diagnostics (Deb, Manning, and Norton 2010; Manning and Mullahy 2001), this study chooses a 
GLM with a log link and gamma distribution for the two expenditure measures, and chooses a 
GLM with a log link and negative binomial distribution for the total number of prescriptions 
filled (Tables B3-B5 in Appendix).  
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2.3   Results 
Table 1 lists the definitions and provides descriptive statistics for all of the variables.  The 
average age of Medicare seniors (treatment group) is 74.1, and the average age of adults without 
Medicare who are ages 55-63 (comparison group) is 58.6.  Compared to adults in the comparison 
group, Medicare seniors are less healthy (e.g., their average physical component summary score 
is 41.5 vs. 47.9 in the comparison group, p<0.001), have more chronic conditions (2.6 vs. 1.8, 
p<0.001), have less formal education (e.g., 26% vs. 12% report less than a high school 
education), and have lower annual household income (36% vs. 19% have household income that 
is less than 199% of FPL).  In the treatment group, African-Americans and Hispanics are 
significantly less healthy, less educated, and have less income than Whites.  This is also the case 
in the comparison group (see Tables A1-A2 in Appendix). 
Table 2 reports the unadjusted trends in the gap between African-Americans and Whites, 
and between Hispanics and Whites prior to Part D.  The second column reports the differences 
between African-Americans and Whites in both the treatment and comparison groups during 
2002-2003, whereas the third column reports such differences during 2004-2005.  The fourth 
column reports the changes in the gap over time, and the fifth column reports the net difference-
in-differences result between the two time periods and between the comparison and treatment 
groups.  Columns 7 through 11 report analogous statistics comparing Whites and Hispanics.   
The two DD columns in Table 2 reveal that prior to Part D, the unadjusted trends in racial/ethnic 
differences were statistically identical in the treatment and comparison groups.  In light of these 
findings, there is a logical basis for adopting a difference-in-differences methodology in this 
dissertation.   
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Table 3 reports for the treatment group the IOM-adjusted estimates of the average values 
for the five outcome measures and the IOM disparities in those outcome measures, prior to and 
after Part D.  Table 4 is a similar table for the comparison group.  The estimates in these tables 
are derived from simulations using the multivariate regressions reported in Appendix Tables B1 
– B5, after assigning African-Americans and Hispanics the same distribution of need-related 
variables that Whites display.  The estimated disparities in Tables 3 and 4 are used in Table 5, 
which summarizes the key findings. 
  Table 5 reports estimates of the effects of Part D on the IOM disparities between 
minorities and Whites, using the difference-in-differences methodology.   It shows that prior to 
2006 there was a 4 percentage point gap (p=0.003) between African-American and White seniors 
in the prevalence of drug insurance.  Following Part D this racial gap fell significantly by 3 
percentage points (p=0.025) to 1 percent.  However, following Part D, in the comparison group 
the gap between African-Americans and Whites fell by 1 percentage point, from 13 to 12%.  
Thus, Part D reduced the racial disparity in drug coverage among Medicare seniors by 2 
percentage points, but this change is not statistically significant (p=0.248).   
Part D reduced the disparity in any-prescriptions-filled between African-American and 
White seniors.  Over the period, the disparity in this outcome fell by 1 percent among Medicare 
seniors, while it increased by 2 percent among the near-elderly.  Thus, the net effect was a 
reduction of 3 percentage points in the racial disparity among seniors (p=0.051).   
Following Part D, the African-American/White disparity in the annual number of 
prescriptions filled and in total annual spending on prescription drugs widened slightly, but the 
change was not significant.  The reason it widened is that, among seniors, following Part D drug 
utilization and total spending on drugs rose more among Whites than they did among African-
14 
 
 
Americans, while racial gaps in utilization and spending stayed about the same in the comparison 
group.   
Over the period the racial disparity in annual out-of-pocket spending on prescription drugs 
declined significantly among Medicare seniors by $58, from $319 to $261 (p=0.015).  However, 
since it also fell in the comparison group, the net result of Part D was an insignificant reduction 
in the disparity by $34 (P=0.229).  (See Tables 3 and 4)  
Columns 7-11 in Table 5 relate to disparities between Hispanics and Whites.  There was no 
disparity in the prevalence of drug coverage between Hispanic and White Medicare seniors 
before or after Part D.  Over the period, the disparity between the Hispanic/White seniors in any-
prescriptions-filled has risen by a trivial amount, from 3 to 4 percent.  In the comparison group, 
however, it has not changed.  Therefore the net effect was a 1 percent insignificant increase in 
the disparity. 
The annual number of prescriptions filled by Hispanic seniors has increased by 5, over the 
period, from 25 to 30 prescriptions (p < 0.001).  This was much larger than the increase in the 
annual number of prescriptions filled by White seniors, which rose by 3, from 30 to 33 
prescriptions.  Meanwhile, in the comparison group the ethnic disparity in the number of 
prescriptions filled increased significantly by 1.5 prescriptions.  Therefore, the net result of Part 
D was a significant reduction in the ethnic disparity among seniors in the annual number of 
prescriptions filled by 3.42 prescriptions (p=0.003).    
Among Medicare seniors the ethnic disparity in total spending on drugs grew slightly over 
the period by $82, from $497 to $579.  In the comparison group it increased significantly by 
$306, from $452 to $758 (p<0.001).  Thus, Part D resulted in a significant reduction of $223 
(p=0.008) in the Hispanic/White disparity in total spending on prescription drugs.   
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Finally, the ethnic disparity in annual out-of-pocket drug spending among seniors fell 
significantly over the period by $50, from $330 to $280, while it increased significantly in the 
comparison group by $113, from $89 to $203.  The net effect of Part D was a $164 significant 
reduction in the ethnic disparity in annual out-of-pocket spending (p<0.001).   
2.4   Discussion 
Three findings emerge from this analysis.  First, Medicare Part D significantly reduced the 
disparity between African-American and White seniors in the percentage of individuals who fill 
any prescriptions during the year.  The disparity fell by 3 percentage points.   
Second, Part D significantly reduced Hispanic/White disparities in the annual number of 
prescriptions filled, in annual out-of-pocket and in total spending on prescription drugs.  It 
reduced the Hispanic/White disparities in the number of prescriptions filled by 3.4, in out-of-
pocket spending by $164, and in total prescription drug spending by $224. 
Third, Part D had no effects on African-American/White disparities in the prevalence of 
drug insurance, in the number of prescriptions filled, in out-of-pocket spending on prescription 
drugs, or on annual total spending on prescription drugs.  Nor did Medicare Part D have any 
effects on Hispanic/White disparities in the prevalence of drug insurance or in the prevalence of 
filling any prescriptions during a year.   
Explanation for the lack of effects on racial/ethnic disparities in the prevalence of drug 
insurance is that by 2005 such disparities were already almost trivial, and the program 
significantly expanded the prevalence of drug coverage within all three subpopulations by 20-24 
percent.  Thus, the old saying, “a rising tide lifts all boats,” would seem appropriate for 
characterizing the effects of Part D on the prevalence of coverage across groups.   
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This research shows that Part D significantly reduced Hispanic/White disparities in 
prescription drug utilization and spending, but had little effect on disparities in these areas for 
African-Americans.  Hispanics’ disparity declines are largely attributable to increases in their 
prescription drug utilization and spending.  It is important to note here that those increases in 
utilization and spending among Hispanics were large enough to essentially lift them onto the 
same footing as African-Americans.  That is, adjusted average utilization and spending are now 
the same for African-American and Hispanic seniors, whereas prior to Part D they were 
significantly lower for Hispanics.   
One explanation for why Hispanics saw larger changes in utilization and spending than 
African-Americans may have to do with Hispanics’ higher rate of enrollment in Medicare 
Advantage (MA) plans that have drug coverage, as opposed to stand-alone PDPs (Neuman, 
Strollo, and Cuterman 2007; Levy et al. 2009).   MA plans are disproportionately located in the 
southwest and California, where many Hispanics live (Neuman et al. 2007).  Some have also 
suggested that, at least historically, the West has had more generous public health and outreach 
programs (Pezzin and Kasper 2002), so education about Part D and the LIS program may have 
been relatively more effective among Hispanics.  Finally, it is important to note that, as shown in 
Table 4, among adults ages 55-63 there were no changes observed in African-American/White 
disparities over the entire period, yet significant increases in Hispanic/White disparities occurred.  
These differences may be explained by the economic hardship of recent years, and the fact that 
disproportionately more Hispanics lost employer-sponsored health insurance over this period, 
which is the main source of drug insurance in this age range (Mahmoudi and Jensen 2012).    
Yet, there are still significant racial and ethnic disparities in prescription drug utilization 
and spending that remain after Part D.  Why?  The persistence in these disparities may be due to 
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a number of factors.  First, there are differences in sources of prescription drug coverage across 
subpopulations, and different sources provide different depths of protection.  Generally speaking, 
employer plans tend to offer the most generous prescription drug benefits, followed by Medicare 
Advantage plans, and stand-alone drug plans (Neuman et al. 2007).  After Part D most seniors 
who have already had employer-sponsored plans kept their employer-sponsored drug insurance 
(Levy et al. 2009).  Previous research suggests, relatively fewer African-American and Hispanic 
seniors report holding employer-sponsored coverage.  More say they have a Medicare Advantage 
plan or Medicaid.  Thus, differences in the nature of drug insurance across groups may partially 
explain the persistence of disparities.  But other reasons have to do with the determinants of 
prescription drug use and spending, more generally.  African-American and Hispanic seniors 
more often lack any usual source of care, they more frequently encounter transportation 
difficulties, and tend to have lower income, less education, and sometimes English language 
barriers, all of which tend to depress their use of healthcare, including prescription drugs.  As 
long as these differences remain there will likely be disparities. 
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Chapter 3: Medicare Part D and Racial/Ethnic Disparities in Utilization of 
Medical Services 
  
Medicare Part D implemented on January 1, 2006 provided affordable drug coverage to 
more than 43 million Medicare beneficiaries.  Lack of access to affordable prescription drugs, 
particularly among older adults who in average have more than one chronic condition to manage, 
has been linked to more serious adverse health events, such as a heart attack or stroke, higher 
rates of hospitalization, and emergency department visits (Heisler et al. 2004; Sokol et al. 2005; 
Jensen and Li 2012).   While Whites have higher rates of visiting physicians’ office, the 
prevalence rate of hospitalization and emergency visits for potentially preventable chronic 
conditions are much higher among African-Americans and Hispanics (Davis, Liu, and Gibbons 
2003; Jiang, Andrews, Stryer, et al. 2005; Dunlop, Manheim, Song, et al. 2002).  According to 
previous research, race/ethnicity and socioeconomic status have substantial effects on mortality 
and utilization of different healthcare services (Gornick, Eggers, Reilly, et al. 1996; Eggers and 
Greenberg 2000; Jha, Fisher, Li, et al. 2005).   
Lack of access to prescription drugs may lead to more severe health conditions, hospital 
admissions that could have arguably been avoided, and more emergency visits.  Although 
affordable drug insurance alone is not sufficient to ensure equitability and efficacy, Part D could 
potentially reduce the existing disparities in utilization of hospital stays and emergency 
department visits.    
Part D has significantly reduced ethnic disparities in utilization of and spending on 
prescription drugs between White and Hispanic seniors (see section 2).  However, it is not clear 
if it has reduced disparities in use of services such as hospitalization and emergency department 
visits.    In this chapter I examine racial/ethnic disparities and the effect of Medicare Part D on 
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three measures: 1) prevalence rate of any hospitalization, 2) prevalence rate of any emergency 
department visit, and 3) total health care cost. 
3.1   Background 
During the 1990’s, many studies have investigated the relation between race and ethnicity, 
and rate of hospitalization (Eggers et al. 2000; Dunlop et al. 2002;  Davis et al. 2003; Jiang et al. 
2005; Allsworth, Toppa, Palin, et al. 2005; Jha et al. 2005).   Using data from 1997-1998 
National Center for Health Statistics (NCHS) and Health Care Financing Administration 
(HCFA), Eggers and colleagues (2000) found higher rates of hospitalization among African-
Americans and Hispanics.  Dunlop et al. (2002) examined the role of economic access in gender 
and racial/ethnic disparities in use of health services among older adults.  Using 1993-1995 data 
from Asset of Health Dynamics among the Oldest Old (AHEAD), they found that economic 
access did not have much effect on gender and ethnic disparities in use of medical services that 
are covered by Medicare.  They found, however, that African-American males had fewer 
physician visits, and both minority and White females had fewer out-patient surgery services.  
Davis et al. (2003) using 1991-1998 hospital data from California examined trends on racial 
disparities in preventable hospitalization during the 1990’s.  They found that African-Americans 
had significantly higher rate of hospitalization in 1991, and the racial disparity grew wider over 
the period of study.  Allsworth and colleagues (2005) using data from the Systematic Assessment 
of Geriatric Drug Use via Epidemiology (SAGE) studied racial/ethnic disparities in diabetic 
medication adherence among the residence of long-term care facilities.  They found that African-
Americans and Hispanics had significantly lower rates of anti-diabetic medication use than 
Whites, which possibly suggests more preventable and pervasive treatments in the long run.  
Jiang et al. (2005) examined racial/ethnic disparity in the rate of preventable hospital 
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readmission rates among people with diabetes.   They used data from 5 different states databases 
of the Healthcare Cost and Utilization Project (HCUP).  They found that among diabetic 
Medicare beneficiaries Whites had a significantly lower readmission rates compared to African-
Americans and Hispanics.  Finally, Jha et al. (2005) using 1992-2001 Medicare data examined 
racial disparities in the use of 9 specific high-cost surgical procedures.  They found that in the 
base year, Whites had a significantly higher rate of utilization for all 9 procedures.  They found, 
over the period, the disparity did not change for 3 of the procedures and grew larger for 5 of 
them.   
Racial/ethnic disparity in the utilization rate of emergency departments has not been 
extensively studied (Baker, Stevens, and Brook 1996; Sarver, Cydulka, and Baker 2002; Ginde, 
Espinola, Camargo 2008).  Baker, Stevens, and Brook (1996) surveyed patients in a public 
emergency department over a 3-month period.  They found African-Americans were more likely 
than Whites and Hispanics to have 2 or more emergency visits.  However, after adjusting for age, 
having a usual source of care, having insurance, and having transportation difficulties, they could 
not associate race and ethnicity with more emergency department use.  Sarver et al. (2002) using 
1996 Medical Expenditure Panel Survey (MEPS) data studied relationship between having a 
usual source of care and non-urgent emergency department visits.  They found significant 
correlations between dissatisfaction with or barriers to meet one’s usual source of care and the 
likelihood of having a non-urgent emergency department visit.  Ginde et al. (2008), using 
National Hospital Ambulatory Medical Care Survey of 1993-2005, examined racial disparity in 
emergency department visits for patients with acute asthma and found that while the rate for 
African-Americans stayed the same over the entire period, from1998 to 2005, emergency-visit 
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rates for Whites dropped significantly by 25 percentage points.   They also found the general 
asthma-related emergency-visit rates are higher among African-Americans and Hispanics. 
3.2   Data and Methods 
Data 
The data used for the analyses in this chapter is identical to the data used for analyses in 
Chapter 2 and is described in detail on pages 6-7.   
Dependent and Independent Variables 
This study examines racial/ethnic disparities in three measures: (1) whether the individual 
had any hospitalization during the past year, (2) whether the individual had any emergency 
department visit during the past year, and (3) positive annual total health care cost. 
The prevalence rates of any hospitalization and any emergency department are measured as 
dichotomous variables that equal 1 if any hospitalization and any emergency department visit 
occurred, respectively.  These two measures are from the utilization section of the MEPS, and 
the positive total health care spending during the past year is from the expenditures section of the 
MEPS.  Before beginning the analysis, total health care spending converted to inflation-adjusted 
2007 dollars using the all-items Consumer Price Index. 
Conceptual framework of the study that guides the choice of explanatory variables for the 
models is the same as what I discussed in chapter 2 and is described in detail on page 8.  
IOM Definition and Measurement of a Disparity 
2
  
This chapter similar to what I discussed in chapter 2 adapts the Institute of Medicine’s 
(IOM) definition of a racial or ethnic disparity.  IOM definition is described in detail on pages 9-
10.  
Difference-in-Differences and Regression Framework for Evaluation 
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The DD methodology and equation that was used to estimate Part D’s effect is the same as 
what I discussed earlier in chapter 2 on pages 10-11.  
For any hospitalization and any emergency department visits, this study fits logistic 
regressions (Tables B6-B7 in Appendix).  For the positive total health care expenditure this study 
fits a generalized linear model (GLM) (McCullagh and Nelder 1989).  On the basis of a modified 
Park test (Park 1966) and other recommended diagnostics (Deb, Manning, and Norton 2010; 
Manning and Mullahy 2001), we chose a GLM with a log link and gamma distribution for the 
positive total health care expenditure (Table B8 in Appendix).  
3.3   Results 
Table 6 reports the unadjusted trends in the gap between African-Americans and Whites, 
and between Hispanics and Whites prior to Part D.  The second column reports the differences 
between African-Americans and Whites in both the treatment and comparison groups during 
2002-2003, whereas the third column reports such differences during 2004-2005.  The fourth 
column reports the changes in the gap over time, and the fifth column reports the net difference-
in-differences result between the two time periods and between the comparison and treatment 
groups.  Columns 7 through 11 report analogous statistics comparing Whites and Hispanics.   
The two DD columns in Table 6 reveal that except for disparity in “any hospitalizations” 
between African-Americans and White, prior to Part D, the unadjusted trends in racial/ethnic 
differences were statistically identical in the treatment and comparison groups.  While racial 
disparity between African-Americans and Whites in “any hospitalization” decreased by 4 
percentage points among seniors, it increased by 5 percentage point among the near-elderly.  As 
a result, the DD effect in unadjusted disparity in “any hospitalization” trend prior to Part D was 9 
percent (p=0.018), making the near-elderly not a suitable comparison group for the DD analysis 
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of Part D’s effect on racial disparity in “any hospitalization.”   Possible explanations for this 
divergence in trend are not explored in this study.  The DD results are not significant for other 
measures of disparities.  Thus, there is a logical basis for adopting a difference-in-differences 
methodology for other measures using the near-elderly, ages 55-63, as the comparison group.   
Table 7 reports for the treatment group the IOM-adjusted estimates of the average values 
for the three outcome measures and the IOM disparities in those outcome measures, prior to and 
after Part D.  Table 8 is a similar table for the comparison group.  The estimates in these tables 
are derived from simulations using the multivariate regressions reported in Appendix Tables B6 
– B8, after assigning African-Americans and Hispanics the same distribution of need-related 
variables that Whites display.  The estimated disparities in Tables 7 and 8 are used in Table 9, 
which summarizes the key findings. 
Table 9 reports the estimated effects of Part D on the IOM disparities between minorities 
and Whites, using the difference-in-differences methodology.   Because of the lack of an 
appropriate comparison group, this study is not evaluating effect of Part D on disparity in 
prevalence of any hospitalizations between White and African-American seniors.   
For Hispanics, Table 7 shows that prior to 2006 there was a 3 percentage point gap (p < 
0.0001) between Hispanic and White seniors in “any hospitalization” rate.  Following Part D the 
disparity did not change.  However, the gap between Hispanics and Whites in comparison group 
fell sharply by 3 percentage point, from 4 to 1 percent.  Thus, Part D significantly increased the 
ethnic disparity in “any hospitalization” between Hispanic and White Medicare seniors by 3 
percentage points (p < 0.001).   
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Part D reduced the disparity in “any emergency department visits” between African-
American and White seniors by 1 percent.  However this reduction was not significant.  Prior to 
2006, there was no disparity in any emergency visits between White and African-American 
seniors.  Over the period, rate of emergency visits fell by 1 percentage point from 15 to 14 
percent among the White seniors, but it increased by 2 percentage point from 15 to 17 percent 
among the African-American seniors.  Similar trend is estimated among the comparison group.  
While the rate of emergency department visit reduced by 1 percentage point from 9 to 8 percent 
among the near-elderly Whites, it increased by 1 percent from 10 to 11 percentage points among 
the near-elderly African-Americans.  Thus, the DD effect of Part D was a trivial and insignificant 
reduction of 1 percent (p=0.133) on racial disparity in any emergency department visit.   
Prior and after Part D, Hispanic seniors had a 1 percentage point higher rate of any 
emergency visit.  Prior to 2006, 16 percent of Hispanic seniors versus 15 percent of White 
seniors used the emergency department.  After Part D, the rate decreased by 1 percent among 
both Whites and Hispanic seniors to 14 and 15, respectively.  Analogous trend is estimated 
among the near-elderly. Prior to Part D, 11 percent of the Hispanic near-elderly had “any 
emergency visit.”  Over the period, the rate dropped by 2 percentage point to 9 percent.  As a 
result, disparity between the near-elderly Whites and Hispanics in “any emergency visit” reduced 
by 1 percentage point.  Thus, the DD effect of Part D was a significant reduction of disparity in 
“any emergency visit” by 1 percent (p=0.004).   
There were significant racial/ethnic disparities in total health care cost prior to and after 
Part D between Whites and minorities in treatment and comparison groups. In general, Whites 
spend significantly more on health care.  For example, estimated average spending of White 
seniors’ prior to Part D was $9,390.  Following Part D, it increased by $166 to $9,556.  
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Meanwhile, total spending among African-American seniors increased by $591 from $8,133 to 
$8,724.   Over the period, a similar trend happened among the near-elderly. While estimated 
average spending among the near-elderly Whites increased by $782 from $5,924 to $6,706, 
estimated average spending among the near-elderly African-Americans also increased by $1,005 
from $4,652 to $5,657.  Thus, the DD effect of Part D for racial disparity in total medical cost 
was an insignificant increase in disparity by a trivial amount of $202 (p=0.735).  Similarly, Part 
D insignificantly increased the ethnic disparity in total medical cost between Whites and 
Hispanic by a trivial amount of $44.81 (p=0.907).  Therefore, over the period of study, Part D 
did not affect the racial/ethnic disparity in total medical cost. 
3.4   Discussions 
Three findings emerge from this analysis.  First, Medicare Part D significantly increased 
the disparity between Hispanic and White seniors in prevalence of any hospitalization by 3 
percentage points. 
Second, Part D significantly reduced Hispanic/White disparity in prevalence of any 
emergency department visits by 1 percentage point.  Part D also reduced the disparity between 
Whites and African-Americans in “any emergency department visits” by 1 percent; however, it 
was not statistically significant. 
Third, Part D had no statistically significant effects on racial/ethnic disparities in total 
medical costs.  Over the period, racial/ethnic disparity in total medical cost increased 
insignificantly among seniors and near-elderly subpopulations.  Thus, significant and persistent 
racial/ethnic disparities in total medical cost remained intact after Medicare Part D.   
This study’s findings suggest that while racial/ethnic disparity between White and minority 
seniors in prevalence rate of “any hospitalization” stays the same over the period, it has increased 
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significantly among the near-elderly.  Over the period, prevalence rate of any hospitalization 
increased significantly more among the near-elderly minorities than among the near-elderly 
Whites.  This might be explained by the fact that the near-elderly minority individuals are 
significantly less healthy, have lower prevalence rate of health insurance, have lower rate of 
visiting physicians, and finally have less access to a usual source of care (Mahmoudi and Jensen, 
2012).  Among Hispanic seniors, the fact that rate of “any hospitalization” increased 
significantly among the near-elderly Hispanics while it did not change among Hispanic seniors 
could be interpreted differently.  One possible explanation for the small but significant difference 
between the near-elderly and senior Hispanics in the prevalence rate of any hospitalization is the 
significant increase in the prescription drug utilization among Hispanic seniors (see Chapter 2).  
Thus, this finding suggests that Part D has been successful in keeping the hospitalization rate low 
among the Hispanic seniors by possibly reducing preventable hospitalization by small but 
significant rate.  Further research among seniors with specific chronic conditions is needed to 
determine the effectiveness of Part D on rate of preventable hospitalization. 
Medicare Part D significantly reduces ethnic disparity between Whites and Hispanics in the 
prevalence of any emergency department visits.  One plausible explanation is that Part D was 
effective in helping Hispanic seniors manage their illnesses via utilization of prescription drugs.   
Third, Part D had no significant effects on racial/ethnic disparity in total medical cost.   
This study suggests that not only Medicare Part D did not offset other medical cost, but also did 
not reduce the disparity in total health care cost.  Over the period, the change in percentage of 
“any hospitalization” and “any emergency department visits” among the minority and White 
seniors were trivial (see Table 8).  Although, over the period, health care cost grew faster among 
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the near-elderly and senior minorities than it did among Whites
4
, near-elderly and senior Whites 
still spend significantly more on health care.   
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Chapter 4: Alternative Definitions of Racial/Ethnic Disparity 
In this chapter I examine the effects of Part D on racial/ethnic disparities in prescription 
drugs using two alternative definitions of a disparity: 1) AHRQ definition and 2) RDE definition. 
4.1   Background 
Prior literature reveals a number of different definitions for a “disparity” in access to and 
utilization of health care.  Conceptually, these definitions fall along a continuum that ranges from 
the simple difference in the mean value of a variable between two population groups (AHRQ, 
2007), to the estimated difference between those groups after controlling for as many available 
covariates as possible (Cook, McGuire, and Miranda 2007).  Some recent papers document that 
the estimated size of a disparity can and often does vary with the particular definition adapted  
(McGuire, Alegria, Cook, et al. 2006).  Indeed, one challenge in reviewing prior research on 
racial and ethnic disparities in access to care is that studies have varied in their definition, 
making it difficult to compare findings across studies, or to determine whether disparities have 
been increasing or diminishing over time.   
Figure 1 illustrates the distinctions between three different definitions that appear in the 
literature.  The first definition of a disparity, suggested by the Agency for Healthcare Research 
and Quality (2007), is the simple difference in the unadjusted means of a measure of access 
between two population groups, such as between Whites and a minority group, such as 
Hispanics.  Some portion of that difference between the two groups is likely attributable to 
differences in the health status and preferences of Whites and Hispanics.  For example, Hispanics 
may be less likely to have seen a doctor over the past year because they tend to be younger than 
Whites and thus have fewer medical problems requiring a doctor’s attention.   
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Under a second definition, a difference in access due to differences in health status or 
differences in personal preferences for care is not considered part of a disparity.  Rather, a 
disparity is a “difference in access or treatment provided to members of different racial or ethnic 
groups that is not justified by the underlying health conditions or treatment preferences of 
individuals” (IOM, 2002).  In terms of Figure 1, this definition considers a disparity to be the 
portion of the simple difference due to differences in health insurance and socio-economic 
factors between Whites and Hispanics, plus the portion due to discrimination, but it excludes the 
top portion due to differences in health status and personal preferences.   
According to a third definition a disparity is what is left over in comparing access between 
Whites and Hispanics, after controlling for as many available covariates as possible, including 
health status, preferences, health insurance, and socio-economic determinants.  In effect, it is the 
coefficient of an indicator for being Hispanic in a fully specified multivariate regression for the 
access variable.  Cook et al. (2007) call this approach the “residual direct effect” (RDE) method 
for defining a disparity.    
Throughout, this dissertation follows the second definition, which is called the IOM 
definition.  This study views it as a middle-ground between the all-or-nothing extremes of 
examining a simple difference in means or using an RDE measure.  It recognizes that socio-
economic factors, such as differences in income and health insurance contribute to disparities in 
access.   
This dissertation implemented the IOM definition by estimating multivariate regression 
models for the access, utilization, and cost measures, and then using those models to simulate an 
answer to the following question: “What would the gap in access, utilization, or cost between the 
minority group and Whites be if the minority individuals had the same health-status as Whites, 
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but all of their own other characteristics?”  This study has not attempted to equalize treatment 
preferences across groups, because of the inherent difficulties of accurately measuring individual 
preferences in sample surveys. 
Depending what definition of a disparity is used, the findings could be substantially 
different.  This section of the dissertation, evaluates the effect of Medicare Part D, using two 
alternative definitions of a disparity: 1) unadjusted average (AHRQ) and 2) residual direct effect 
of race (RDE) 
4.2   Results 
Unadjusted Average    
Table 10 reports the unadjusted average and the corresponding disparities for the eight 
outcome measures reported separately in chapters 2 and 3 for the White, African American, and 
Hispanic seniors prior to and after Medicare Part D.  Table 10 reveals that African-American in 
comparison to Whites had significantly higher prescription drug utilization prior and after Part D 
(32 versus 27 prior to Part D, p=0.002; and 33 versus 30 after Part D, p=0.005).  It also shows 
that there were $125 (p=0.019) and $151 (p < 0.0001) gaps between Whites and African-
American seniors in out-of-pocket prescription drug spending before and after Part D, 
respectively.  Finally it shows, while there was no significant disparity in “any emergency visits” 
between White and African-American seniors prior to Part D, disparity grew significantly to 4 
percent (p=0.002) after Part D.  Table 11 is similar to Table 10 but for the comparison group.  It 
reveals that there were 10 percent (p < 0.0001) and 9 percent (p < 0.0001) unadjusted disparities 
in the prevalence of drug coverage between the near-elderly Whites and African-Americans prior 
to and after Part D.  It also shows that prior to Part D the near-elderly African-Americans filled 3 
prescription drugs (p=0.036) more than the near-elderly Whites; the gap reduced by 2 to 1 after 
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Part D.  Finally, after Part D, racial disparity in prevalence of “any hospitalization” and “any 
emergency department visit” increased significantly (p < 0.0001), showing higher utilization 
rates for the near-elderly African-Americans.   
The unadjusted differences in Tables 10 and 11 are used in Table 12, which summarizes 
the DD effect of Part D, using unadjusted average measures.  Using unadjusted average 
measures, Table 12 does not reveal any significant DD effect on reported disparities between 
White and African-American seniors. 
Hispanic measures are reported on the right sides of the Tables 10-12.  Table 10 shows 4 
percent (P=0.001) and 3 percent (p=0.010) gap in the prevalence of any prescriptions filled 
between White and Hispanic seniors prior and after Part D, respectively.  It also shows $222 
(p=0.034) disparity in total prescription spending before Part D, which was reduced to $169 
(p=0.200) afterward.  Hispanic seniors out-of-pocket cost of prescription drugs were 
significantly lower than White seniors prior to ($266, p < 0.0001) and after ($207, p < 0.0001) 
Part D.  Finally, Hispanic seniors in comparison to White seniors had lower prevalence of any 
hospitalization prior to Part D (16 percent versus 18 percent, p=0.092).  Table 11 reveals 
significantly higher levels of disparities in all measures of outcome between the near-elderly 
Whites and Hispanics in comparison with Whites and Hispanic seniors.  For instance, prior to 
Part D, there was 27 percent (p < 0.0001) disparity between the near-elderly Whites and 
Hispanics in the prevalence of drug insurance, which was reduced to 22 percent (p < 0.0001) 
over the period.  Furthermore, Over the period, disparities between the near-elderly Whites and 
Hispanics in total cost (from $262 to $577, p=0.030) and in out-of-pocket cost of prescription 
drugs (from $39 to $136, p=0.103) grew larger; and disparities in prevalence of drug coverage 
(from 27% to 22%, p=0.114) and any hospitalization (from 4 percent to 2 percent, p=0.104) grew 
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smaller. Table 12 summarizes the DD effects using the unadjusted averages.  Columns 7-9 
summarize the findings in Table 10 and 11, and column 10 displays Part D’s effect on disparities 
between White and Hispanic seniors.  It shows that Part D significantly reduced disparities in 
total number of prescriptions filled (or refilled) by 3.81 (p=0.099), and in total cost of 
prescription drugs by $261 (p=0.094). 
Residual Direct Effect 
Table 13 reports the RDE estimated values, and the corresponding racial/ethnic disparities 
for the eight outcome measures reported separately in chapters 2 and 3 for White, African 
American, and Hispanic seniors prior to and after Medicare Part D, using the IOM definition.  
First, Table 13 reveals that our findings for the prevalence of drug insurance, any prescriptions 
filled, any hospitalization, and any emergency visit, using the RDE approach mirror our findings 
using the unadjusted averages.  For utilization of prescription drugs, it shows that African-
American seniors in comparison to White seniors had significantly higher prescription drug 
utilization prior to and after Part D (35 versus 29 prior to Part D, p < 0.0001; and 37 versus 
31after Part D, p < 0.0001).  It also shows that prior to Part D, total estimated average of 
prescription spending was higher among African-American seniors than it was among White 
seniors ($2357 vs. $2133, p=0.002); however, out-of-pocket cost of prescription drugs was lower 
for African-American seniors in comparison with White seniors both before and after Part D 
($989 vs. $1,088 prior to Part D, p < 0.0001; $586 vs. $726 after Part D, p < 0.0001).  Table 13 
shows that prior to Part D African-American seniors had significantly lower total health care cost 
than White seniors (by $581, p = 0.055).  After Part D, however, Table 13 does not show any 
significant disparity between White and African-American seniors.  Table 14 is similar to Table 
13 but for the comparison group.  Similar to Table 13, findings from prevalence of drug 
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insurance, any prescription filled, any hospitalization, and any emergency visits mirror the 
findings from Table 11, using unadjusted averages.  Table 14 reports higher utilization of drugs 
among the near-elderly African-Americans in comparison with the near-elderly Whites, prior to 
and after Part D (23 vs. 20 prior to, p=0.005; and 22 vs. 20 after, p=0.003).  It also shows a 
trivial but lower out-of-pocket drug cost among the near-elderly African-American vs. the near-
elderly Whites after Part D ($475 vs. $500, p=0.061).   
The RDE adjusted differences in Tables 13 and 14 are reported in Table 15, which 
summarizes the DD effect of Part D.  Table 15, similar to Table 12, using unadjusted averages, 
does not reveal any significant DD effect on reported disparities between White and African-
American seniors. 
Hispanic measures are reported on the right side of the Tables 13-15.  Table 13 shows 
higher utilization of prescription drugs among Hispanic seniors in comparison with White 
seniors after Part D (by 3, p=0.012).  It also reports lower out-of-pocket cost (by $211prior to 
Part D, p < 0.0001; and by $200 after Part D, p < 0.0001), and lower total health care cost prior 
to Part D (by $1060, p < 0.0001) among Hispanic seniors in comparison with White seniors.   
Table 14 reveals significantly higher levels of disparities in all measures of outcome between the 
near-elderly Whites and Hispanics in comparison with Whites and Hispanic seniors.  It reports 
lower utilization of prescription drug (by 1.87 prior to Part D, p=0.016; and by 3.65 after Part D, 
p < 0.0001), lower prescription drug spending (by $250 prior to Part D, p < 0.0001; and by $543 
after Part D, p < 0.0001 ), and lower total health care cost (by $2,396 prior to Part D, p < 0.0001 
; and by $2,577 after Part D, p < 0.0001) among the near-elderly Hispanics versus the near-
elderly Whites.  Table 14 also shows a significant reduction in out-of-pocket cost of prescription 
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drugs among the near-elderly Hispanics over the period, which increased the disparity between 
the near-elderly Whites and Hispanics in out-of-pocket spending from $7 to $144 (p < 0.0001).   
Table 15 summarizes the DD effects using the RDE adjusted method.  Columns 7-9 
summarize the findings in Table 13 and 14, and column 10 displays Part D’s effect on disparities 
between White and Hispanic seniors.  It shows that Part D significantly reduced disparities in 
total number of prescriptions filled (or refilled) by 4.87 (p=0.007), in total cost of prescription 
drugs by $321 (p=0.015), in total out-of-pocket spending by $147 (p < 0.0001), and in 
prevalence of any emergency visit by 4 percent (p< 0.0001).  Furthermore, it reports that Part D 
significantly increased the disparity in prevalence rate of drug insurance by 5 percent (p=0.073) 
and in prevalence of any hospitalization by 2 percent (p=0.017). 
4.3   Discussion 
The main finding using unadjusted averages and the RDE definition suggests that there are 
fundamental differences between reported racial/ethnic disparities and therefore Part D’s effects 
using IOM versus other alternative definitions.   
Findings from this study supports previous research using different definitions of a 
racial/ethnic disparity (McGuire et al. 2006; Cook et al. 2007) in substantial differences between 
IOM and other disparity definitions.  IOM adjusted disparity unlike the other two definitions, 
predicts a counter-factual measure of a disparity solely based on Socioeconomic and other non-
need related characteristics of individuals.  Disparities do not define all differences; they only 
define part of differences that are unjust (Cook, McGuire, and Zuvekas 2009).  Although 
minority groups are significantly younger, they are less healthy than Whites (Table A1-A2 in 
Appendix).  Differences that are based on lower health needs due to being younger or differences 
that are based on higher health needs due to being less healthy do not reveal unjust differences.  
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IOM definition of a disparity allows differences that are due to individuals’ socioeconomic 
status, health insurance, health care operation, or discrimination to be included.   Therefore, by 
adjusting for the need related determinants of demand for health care services, IOM allows 
socioeconomic aspects of demand to be revealed.  For instance, it might be more difficult for 
individuals with lower socioeconomic status to either pay for prescription drugs or choose an 
appropriate Part D plan.  Since minorities are disproportionately represented in lower 
socioeconomic groups, their utilization of and spending in prescription drugs are affected by 
their status.  To summarize, showing total average differences (the AHRQ definition) or showing 
only the discrimination part of a disparity (the RDE definition) could be misleading.  Thus, this 
dissertation advocates for the IOM definition of a disparity. 
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Chapter 5: Conclusion 
This dissertation seeks to evaluate the effect of Medicare Part D on existing racial/ethnic 
disparities between White and African-American seniors, and White and Hispanic seniors.   
Using the IOM definition of a disparity, chapter 2 of this dissertation evaluates the effect of Part 
D on disparities in: 1) prevalence of drug insurance, 2) prevalence of any prescriptions filled, 3) 
total positive number of prescriptions filled, 4) total positive cost of prescription drugs, and 5) 
positive out-of-pocket cost of prescription drugs.  Findings suggest that Part D reduced 
disparities between White and African-American seniors in prevalence of any prescriptions filled 
and between White and Hispanic seniors in total number of prescriptions filled, and in total and 
out-of-pocket cost of prescription drugs.  Using the same dataset and methodology, chapter 3 
examines the effects of Medicare Part D on disparities in: 1) prevalence of any hospitalization, 2) 
prevalence of any emergency department visit, and 3) total health care cost.  Findings suggest no 
effects on disparities between Whites and African-American seniors.  However, disparities 
between White and Hispanic seniors changed differently.  This analysis suggests Medicare Part 
D increased disparity in prevalence of any hospitalization and reduced it in prevalence of any 
emergency department visit.  Finally, chapter 4 of this dissertation examines effects of Medicare 
Part D on all eight measures of disparities discussed in chapter 2 and 3, using two alternative 
definitions of a disparity: the unadjusted means and the RDE.  The findings suggest a substantial 
difference between the three definitions.   
This dissertation has a number of limitations.  First, the most suitable comparison group, 
for this analysis, would have been a group of Medicare beneficiaries ages 65 and older who were 
not eligible for Part D.   However, such a group does not exist, and therefore like most prior 
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studies (Basu et al. 2010; Liu et al. 2011), this study chose adults ages 55-63 (without Medicare) 
as the comparison group.  Second, there may be differences in preferences and attitudes across 
racial and ethnic groups that this study was unable to measure, and these may have contributed to 
racial/ethnic disparities in access and utilization (Ayanian, Cleary, Weissman, et al. 1999).  
Third, because of their small sample sizes in MEPS, this study was unable to distinguish between 
Cubans, Puerto Ricans, Mexicans, and other Hispanics within the overall Hispanic population.  
Finally, this dissertation examined all Medicare seniors.  Thus, the results might differ for 
specific sub-groups of Medicare beneficiaries, such as seniors with specific chronic conditions.           
In summary, Medicare Part D has reduced some racial/ethnic disparities related to 
prescription drugs among Medicare seniors.   However, significant racial and ethnic disparities 
still persist in utilization of and spending on prescribed medications, in utilization of hospitals 
and emergency departments, and in total healthcare cost.   
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Notes: 
1. These sample counts exclude 8,561 MEPS respondents who had missing data on variables 
used in our analysis (all described below) or who had non-positive MEPS sampling weights.  
In the treatment group 2,642 individuals in 2002-2005 and 2,646 individuals in 2006-2009 
were excluded for these reasons, and in the comparison group, 1,458 individuals in 2002-
2005 and 1,815 individuals in 2006-2009 were excluded for these reasons. 
2. This dissertation estimated disparities using two other alternative definitions of a 
racial/ethnic disparity: the unadjusted difference across groups in the average value of the 
outcome measure, and the “residual direct effect” estimate of a disparity (Cook et al. 2007).  
These results are presented in chapter 4.   
3. This dissertation applied the paradigm set out by Hosmer and Lemshow (2000) to determine 
which interaction terms of the Xi’s with the race/ethnicity indicators to include in each model 
and which to exclude.  This study further test “variance inflation factors” to verify that each 
model was multicollinearity-free (Kmenta 1971). 
4. Among the seniors, total health care cost grew by 2 percent among the Whites, 7 percent 
among African-Americans, and 5 percent among the Hispanics.  Among the near-elderly, 
total health care cost grew by 13% among Whites, 22 percent among African-Americans, and 
32 percent among Hispanics.  The percentage increase among the near-elderly and senior 
minorities were significant at alpha=0.01 level. 
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Figure 1 - Measuring Disparity in Access to Healthcare: Unadjusted Difference, Need-Related 
Adjusted Disparity, and Discrimination. 
 
 
 
Note: Adapted from McGuire (2006)
40 
 
 
Table 1: Characteristics of the Comparison Group (Individuals without Medicare, ages 55-63) and the Treatment Group 
(Medicare Beneficiaries, ages 65 and Older) Before Part D 
  Comparison
a
 Treatment
b
 
N  7,879 10,943 
Independent Variables Description Mean SE Mean SE 
Need-related      
Age* age at the beginning of the year 58.60 0.05 74.09 0.11 
Female* 1 if individual is female 0.52 0.01 0.58 0.01 
Poor/Fair Health* 1 if individual rates his/her health as poor or fair 0.15 0.01 0.22 0.01 
Poor/Fair Mental Health* 1 if individual rates his/her mental health as poor or fair 0.06 0.00 0.08 0.00 
PCS* physical component summary SF12 47.86 0.17 41.48 0.17 
MCS mental component summary SF12 52.06 0.15 52.14 0.15 
Function_Index
c
* Index of Physical Limitation 3.16 0.12 8.03 0.16 
Chronic_Index
d
* Index of 10 diagnosed/reported chronic conditions 1.78 0.03 2.61 0.03 
Diabetes* 1 if individual diagnosed with diabetes 0.11 0.00 0.17 0.01 
Heart* 1 if individual has any heart problem 0.15 0.01 0.32 0.01 
Asthma 1 if individual diagnosed with asthma 0.10 0.00 0.09 0.00 
Arthritis* 1 if individual diagnosed with arthritis 0.36 0.01 0.53 0.01 
High Blood Pressure* 1 if individual diagnosed with high blood pressure 0.43 0.01 0.61 0.01 
Stroke* 1 if individual has ever had a stroke 0.03 0.00 0.10 0.00 
Marital Status      
Married* 1 if individual is married 0.70 0.01 0.55 0.01 
Education      
Less than High School 1 if individual has no high school diploma 0.12 0.01 0.26 0.01 
High School (omitted)* 1 if individual has high school diploma 0.51 0.01 0.50 0.01 
College and Graduate 
School* 
1 if individual has a college or graduate degree 0.30 0.01 0.19 0.01 
Ot er Degree* 1 if individual has other degrees 0.08 0.01 0.05 0.00 
Household Income Level      
Poor or Near Poor* 1 if household income < 125% FPL 0. 11 0.00 0.16 0.00 
Low Income (omitted)* 1 if household income is 125-199% FPL 0.08 0.00 0.20 0.01 
Middle Income* 1 if household income is 200-399% FPL 0.25 0.01 0.30 0.01 
High Income* 1 if household income >=400% FPL 0.56 0.01 0.33 0.01 
Health Insurance       
Medicaid* 1 if individual has Medicaid 0.04 0.00 0.08 0.00 
Private HMO Insurance* 1 if individual holds private HMO insurance 0.31 0.01 0.09 0.01 
Private Non-HMO 
Insurance 
1 if individual holds private non-HMO insurance 0.48 0.01 0.45 0.01 
No Private 
Insurance(omitted)* 
1 if individual holds no private insurance 0.21 0.01 0.46 0.01 
Health Habits      
Exercise* 1 if individual does exercise         0.58 0.01 0.50 0.01 
Smoker* 1 if individual smokes 0.20 0.01 0.10 0.00 
Attitude Toward Insurance      
Insurance Not Needed 1 if individual thinks health insurance is not needed 0.06 0.00 0.06 0.00 
Insurance Not Worth Cost* 1 if individual thinks health insurance is not worth the 
cost 
0.23 0.01 0.16 0.01 
Location      
Northeast 1 if individual lives in Northeast 0.20 0.01 0.20 0.01 
    Continued 
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Table 1 Continued      
  Comparison Treatment 
N  7,879 10,943 
Independent Variables Description Mean SE Mean SE 
Location      
Midwest 1 if individual lives in Midwest  0.25 0.01 0.23 0.01 
South 1 if individual lives in South 0.36 0.01 0.37 0.01 
West (omitted ) 1 if individual lives in West  0.19 0.01 0.20 0.01 
Metropolitan Area 1 if individual lives in a statistical metropolitan area 0.80 0.01 0.78 0.01 
Language      
English Language 1 if language of the interview is English 0.96 0.00 0.97 0.00 
Source: Data are from the household component files of the 2002-2005 Medical Expenditure Panel Survey. 
Notes: The variables listed are the explanatory variables in the estimated regression models. 
Tables A1-A2 in the Appendix report detailed descriptive statistics stratified by race and ethnicity for the comparison and treatment 
groups for the periods before and after Medicare Part D. 
 a Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
b Treatment group consists of Medicare beneficiaries, ages 65 and older, who  self-report being White, African-American, or 
Hispanic. 
c Function-Index is an index of limitations on activities of daily living (ADLs) and instrumental activities of daily living (IADLs). 
d Chronic-Index is summed across 10 conditions: diabetes, asthma, high blood pressure, coronary heart disease, angina, heart    
attack, other heart disease, stroke, joint pain, and emphysema.   
* The mean of this variable differs significantly between the comparison and treatment group at the alpha = 0.01 level. 
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Table 2 – Trends in the Unadjusted Differences between Whites and African Americans, and between Whites and Hispanics, for Five Outcomes Related to 
Prescription Drugs before the Introduction of Medicare Part D  
 
Whites vs. African-Americans Whites vs. Hispanics 
Outcome Measures Difference 
2002-2003 
Difference 
2004-2005 
Difference 
over time 
DD t 
(p-value) 
Difference 
2002-2003 
Difference 
2004-2005 
Difference 
over time 
DD t 
(p-value) 
Drug Insurance           
    Treatment (65+) 0.01 0.01 0.00 0.00 0.01 0.03 -0.01 -0.04 -0.01 -0.20 
    Comparison (55-63) 0.10 0.10 0.00  (0.993) 0.27 0.24 -0.03  (0.844) 
Any Prescriptions Filled           
    Treatment (65+) 0.04 0.01 -0.03 -0.06 -1.6 0.05 0.04 -0.01 -0.01 -0.19 
    Comparison (55-63) 0.04 0.07 0.03  (0.111) 0.13 0.13 0.00  (0.849) 
Total Number Rx filled           
    Treatment (65+) -2.93 -3.11 -0.18 -2.18 -0.73 3.22 1.77 -1.45 -1.03 -0.41 
    Comparison (55-63) -3.27 -1.27 2.00  (0.465) 3.60 3.18 -0.42  (0.685) 
Rx Total  Spending           
    Treatment (65+) -$80.05 $72.00 $152.05 $18.43 0.08 $235.36 $316.98 $81.62 $5.81 0.02 
    Comparison (55-63) -$26.56 $107.06 $133.62  (0.934) $269.69 $345.50 $75.81  (0.980) 
Rx Out-of-Pocket  Spending          
    Treatment (65+) $183.53 $165.17 -$18.36 -$85.19 -0.81 $249.55 $296.15 $46.60 $137.86 1.12 
    Comparison (55-63) $17.13 $83.96 $66.83  (0.421) $109.91 $18.65 -$91.26  (0.263) 
 
Source: Data are from the household component files of the 2002-2003 and 2004-2005 Medical Expenditure Panel Survey.  
Notes: Estimates are for comparison and treatment groups and are based on the unadjusted averages of outcome measures. 
Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
Treatment group consists of Medicare beneficiaries, ages 65 and older, who self-report being White, African-American, or Hispanic. 
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Table 3 – IOM Estimates for the Treatment Group of Outcomes Related to Prescription Drugs, and Disparities during 2002-2005 and 2006-2009 between Whites 
and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Drug Insurance (%) 73% 94% 69%*** 93%*** -4% -1%++ 72% 94% -1%   0%+ 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Any Prescriptions Filled (%) 93% 93% 86%*** 87%*** -7% -6% 90%*** 89%*** -3% -4% 
     (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Total Number Rx filled (#) 30.44 33.20 28.00*** 29.62*** -2.44 -3.58 24.97*** 29.65*** -5.47 -3.55++ 
 (7,688) (6,533) (1,201) (1,423)   (1,236) (1,196)   
Rx Total  Spending ($) $2131.78 $2393.97 $1755.13*** $1880.89*** -$376.65 -$513.08+ $1634.38*** $1814.43*** -$497.40 -$579.54 
     (7,688) (6,533) (1,201) (1,423)   (1,236) (1,196)   
Rx Out-of-Pocket ($) $1092.12 $727.78 $773.12*** $466.57*** -$319.00 -$261.21++ $761.88*** $447.64*** -$330.24 -$280.14+ 
     (7,616) (6,387) (1,181) (1,374)   (1,196) (1,158)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
Notes: Estimates are for Medicare beneficiaries, ages 65 and older, who self-report being White, African-American, or Hispanic.  
The numbers in parentheses are the number of individual in this sample category.  Estimates of number of prescriptions filled, total prescription cost, and out-of-pocket 
cost are based on samples with positive amounts of utilization and expenditure.  
*** Significantly different from the estimate for Whites at the alpha = 0.01 level. 
+, + + Significantly different from the 2002-2005 estimate at the alpha=0.10 and 0.05 level, respectively. 
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Table 4 – IOM Estimates for the Comparison Group of Outcomes Related to Prescription Drugs, and Disparities during 2002-2005 and 2006-2009 between 
Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Drug Insurance (%) 88% 90% 75%*** 78%*** -13% -12% 61%*** 68%*** -27% -22%+++ 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Any Prescriptions Filled (%) 84% 83% 72%*** 69%*** -12% -14% 72%*** 71%*** -12% -12% 
     (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Total Number Rx filled (#) 21.63 22.38 18.34*** 18.29*** -3.29 -4.09 16.52*** 15.77*** -5.11 -6.61++ 
 (4,741) (4,472) (808) (1,085)   (871) (1,024)   
Rx Total  Spending ($) $1592.00 $1765.31 $1118.66*** $1282.32*** -$473.34 -$482.99 $1140.15*** $1007.52*** -$451.85 -$757.79+++ 
     (4,741) (4,472) (808) (1,085)   (871) (1,024)   
Rx Out-of-Pocket ($) $573.49 $516.76 $418.46*** $385.21*** -$155.03 -$131.55 $484.13*** $313.82*** -$89.36 -$202.94+++ 
     (4,691) (4,385) (792) (1,036)   (845) (997)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey.  
Notes: Estimates are for adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic.    
The numbers in parentheses are the number of individual in this sample category.  
 Estimates of number of prescriptions filled, total prescription cost, and out-of-pocket cost are based on samples with positive amounts of utilization and expenditure.  
*** Significantly different from the estimate for Whites at the alpha = 0.01 level. 
++, + + +Significantly different from the 2002-2005 estimate at the alpha=0.05 and 0.01 level, respectively. 
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Table 5 – Difference-in-Differences Estimates of Effects of Medicare Part D on IOM Disparities in Five Outcomes Related to Prescription Drugs between 
Whites and African-Americans, and between Whites and Hispanics 
 
Whites Vs. African-Americans Whites Vs. Hispanics 
Outcome Measures Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
DD t 
(p-value) 
Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
  DD t 
(p-value) 
Drug Insurance           
    Treatment (65+) -0.04 -0.01 0.03 0.02 1.16 -0.01 0.00 0.01 -0.04 -1.55 
    Comparison (55-63) -0.13 -0.12 0.01  (0.248) -0.27 -0.22 0.05  (0.125) 
Any Prescriptions Filled           
    Treatment (65+) -0.07 -0.06 0.01 0.03 1.96 -0.03 -0.04 -0.01 -0.01 -0.26 
    Comparison (55-63) -0.12 -0.14 -0.02  (0.051) -0.12 -0.12 0.00  (0.798) 
Total Number Rx filled           
    Treatment (65+) -2.44 -3.58 -1.14 -0.34 -0.27 -5.47 -3.55 1.92 3.42 2.97 
    Comparison (55-63) -3.29 -4.09 -0.80  (0.787) -5.11 -6.61  -1.50  (0.003) 
Rx Total  Spending           
    Treatment (65+) -$376.65 -$513.08 -$136.43 -$126.78 -1.33 -$497.40 -$579.54 -$82.14 $223.80 2.66 
    Comparison (55-63) -$473.34 -$482.99 -$9.65  (0.184) -$451.85 -$757.79 -$305.94  (0.008) 
Rx Out-of-Pocket  Spending          
    Treatment (65+) -$319.00 -$261.21 $57.79 $34.31 1.21 -$330.24 -$280.14 $50.10 $163.68 4.56 
    Comparison (55-63) -$155.03 -$131.55 $23.48  (0.229) -$89.36 -$202.94 -$113.58  (0.000) 
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey.  
Notes: Estimates for the comparison and treatment groups are based on the adjusted regression models reported in Appendix Tables B1-B5 and the IOM disparity estimates 
from Tables 3 and 4.   
Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
Treatment group consists of Medicare beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic. 
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Table 6 – Trends in the Unadjusted Differences between Whites and African Americans, and between Whites and Hispanics, for any Hospitalization, any 
Emergency Department Visits, and Total Health Care Cost before the Introduction of Medicare Part D  
 
Whites Vs. African-Americans Whites Vs. Hispanics 
Outcome Measures Difference 
02-03 
Difference 
04-05 
Difference 
over time 
DD t 
(p-value) 
Difference 
02-03 
Difference 
04-05 
Difference 
over time 
DD t 
(p-value) 
Any Hospitalization           
    Treatment (65+) 0.00 0.04 0.04 0.09 2.37 -0.02 -0.02 0.00 0.02 1.03 
    Comparison (55-63) 0.04 -0.01 -0.05  (0.018) -0.02 -0.04 -0.02  (0.305) 
Any ED Visits           
    Treatment (65+) 0.01 0.02 0.01 0.01 0.24 0.00 -0.02 -0.02 0.02 0.47 
    Comparison (55-63) 0.03 0.03 0.00  (0.808) 0.04 0.00 -0.04  (0.635) 
Total Medical Cost           
    Treatment (65+) -$37.68 -$137.25 -$99.57 $675.01 0.44 -$78.51 -$856.69 -$778.18 $869.19 0.60 
    Comparison (55-63) $306.85 -$467.73 -$774.58  (0.663) -$1228.94 -$2876.31 -$1647.37  (0.552) 
 
Source: Data are from the household component files of the 2002-2003 and 2004-2005 Medical Expenditure Panel Survey.  
Notes: Estimates are for comparison and treatment groups and are based on unadjusted averages of outcome measures. 
Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
Treatment group consists of Medicare beneficiaries, ages 65 and older, who self-report being White, African-American, or Hispanic. 
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Table 7 – IOM Estimates for the Treatment Group of Outcomes Related to any Hospitalization, any Emergency Department Visits, and Total Health Care Cost, 
and Disparities during 2002-2005 and 2006-2009 between Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Any Hospitalization (%) 19% 18% 19% 18% 0% 0% 16%*** 15%*** -3% -3%+ 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Any ED Visits (%) 15% 14% 15% 17%*** 0% 3%+++ 16%* 15%** 1% 1% 
     (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Total Medical Cost (S) $9390.88 $9556.95 $8133.01*** $8724.14*** -$1257.87 -832.81 $7677.59*** $8054.56*** -$1713.29 -$1502.39 
 (8,075) (6,858) (1,246) (1,482)   (1,290) (1,255)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
Notes: Estimates are for Medicare beneficiaries, ages 65 and older, who self-report being White, African-American, or Hispanic.  
The numbers in parentheses are the number of individual in this sample category.  Estimates of total medical cost are based on samples with positive amounts of 
expenditure.  
*, **, *** Significantly different from the estimate for Whites at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
+, + + + Significantly different from the 2002-2005 estimate at the alpha=0.10 and 0.01 level, respectively. 
  
4
8
 48
 
Table 8 – IOM Estimates for the Comparison Group of Outcomes Related to Hospitalization, Emergency Department, and Total Health Care Cost, and 
Disparities during 2002-2005 and 2006-2009 between Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Any Hospitalization (%) 9% 8% 8%*** 11%*** -1% 3%+++ 5%*** 7%*** -4% -1%+++ 
 (5,663) (5376) (1,003) (1,383)   (1,213) (1,443)   
Any ED Visits (%) 9% 8% 10%*** 11%*** 1% 3%+++ 11%*** 9%*** 2% 1%+++ 
     (5,663) (5376) (1,003) (1,383)   (1,213) (1,443)   
Total Medical Cost (S) $5924.13 $6706.41 $4652.12*** $5657.09*** -$1272.01 -$1049.32 $2996.01*** $3944.38*** -$2928.12 -$2762.03 
 (5,321) (5,050) (881) (1,199)   (1,001) (1,182)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey.  
Notes: Estimates are for adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic.    
The numbers in parentheses are the number of individual in this sample category.  Estimates of total medical cost are based on samples with positive amounts of 
expenditure.   
*** Significantly different from the estimate for Whites at the alpha = 0.01 level. 
+ + +Significantly different from the 2002-2005 estimate at the alpha=0.01 level. 
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Table 9 – Difference-in-Differences Estimates of Effects of Medicare Part D on IOM Disparities in any Hospitalization, any Emergency Department Visits, and 
Total Health Care Cost between Whites and African-Americans, and between Whites and Hispanics 
 
Whites vs. African-Americans Whites vs. Hispanics 
Outcome Measures Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
DD t 
(p-value) 
Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
  DD t 
(p-value) 
Any Hospitalization           
    Treatment (65+) 0.00 0.00 0.00 - - -0.03 -0.03 0.00 -0.03 -4.88 
    Comparison (55-63) -0.01 0.03 0.04  - -0.04 -0.01 0.03  (0.000) 
Any ED Visits           
    Treatment (65+) 0.00 0.03 0.03 0.01 1.51 0.01 0.01 0.00 0.01 2.91 
    Comparison (55-63) 0.01 0.03 0.02  (0.133) 0.02 0.01 -0.01  (0.004) 
Total Medical Cost          
    Treatment (65+) -$1257.87 -$832.81 -$425.06 -$202.37 -0.34 -$1713.29 -$1502.39 -$210.90 -$44.81 -0.12 
    Comparison (55-63) -$1272.01 -$1049.32 -$222.69  (0.735) -$2928.12 -$2762.03 -$166.09  0.907 
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey.  
Notes: Estimates for the comparison and treatment groups are based on the adjusted regression models reported in Appendix Tables B6-B8 and the IOM disparity estimates 
from Tables 7 and 8.   
Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
Treatment group consists of Medicare beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic. 
 
 
  
5
0
 50
 
 Table 10 – Unadjusted Average for the Treatment Group of Outcomes Related to Prescription Drugs, and Disparities during 2002-2005 and 2006-2009 between 
Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Drug Insurance (%) 73% 94% 73% 94% 0% 0% 73% 94% 0% 0% 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Any Prescriptions Filled (%) 93% 93% 92% 92% -1% -1% 89%*** 90%*** -4% -3% 
     (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Total Number Rx filled (#) 27.51 30.09 32.87*** 33.73*** 5.36 3.64 26.34 31.42 -1.17 1.33 
 (7,688) (6,533) (1,201) (1,423)   (1,236) (1,196)   
Rx Total  Spending ($) $1,979.89 $2,230.87 $2,123.54 $2,243.95 $143.65 $13.08  $1,757.48**   $2,061.87   -$222.41  - $169.00  
     (7,688) (6,533) (1,201) (1,423)   (1,236) (1,196)   
Rx Out-of-Pocket ($) $1,039.45 $657.12 $913.96** $505.83*** -$125.49 -$151.29  $773.37***   $449.48***   -$266.08   -$207.64  
     (7,619) (6,387) (1,181) (1,374)   (1,196) (1,158)   
Any Hospitalization (%) 18% 17% 20% 19% 2% 2% 16%* 15% -2% -2% 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Any Emergency Visit (%) 19% 18% 20% 22%*** 1% 4%+ 18% 18% -1% 0% 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Total Health Care Cost($) $8,957.50 $8,929.14 $8,877.43 $9,350.99 -$80.07 $421.85 $8,489.33 $9,085.22 -$468.17 $156.08 
 (8,075) (6,858) (1,246) (1,482)   (1,290) (1,255)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
Notes: Estimates are for Medicare beneficiaries, ages 65 and older, who self-report being White, African-American, or Hispanic.  
The numbers in parentheses are the number of individual in this sample category.  Estimates of number of prescriptions filled, total prescription cost, out-of-pocket cost, 
and total healthcare cost are based on samples with positive amounts of utilization and expenditure.  
**, *** Significantly different from the estimate for Whites at the alpha = 0.05 and 0.01 level, respectively. 
+ Significantly different from the 2002-2005 estimate at the alpha=0.10 level. 
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Table 11 – Unadjusted Average for the Comparison Group of Outcomes Related to Prescription Drugs, and Disparities during 2002-2005 and 2006-2009 between 
Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Drug Insurance (%) 88% 90% 78%*** 81%*** -10% -9% 61%*** 68%*** -27% -22% 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Any Prescriptions Filled (%) 84% 83% 81% 79%*** -3% -4% 72%*** 70%*** -12% -13% 
     (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Total Number Rx filled (#) 18.14 18.81 21.06** 19.79 2.92 0.98 15.08*** 14.44*** -3.06 -4.37 
 (4,741) (4,472) (808) (1,085)   (871) (1,024)   
Rx Total  Spending ($) $1,381.12 $1,552.85 $1,391.33 $1,516.54 $10.21 -$36.31 $1,118.69*** $975.43*** -$262.43 -$577.42++ 
     (4,741) (4,472) (808) (1,085)   (871) (1,024)   
Rx Out-of-Pocket ($) $504.30 $439.51 $479.14 $389.28 -$25.16 -$50.23 $465.16 $303.32*** -$39.14 -$136.19+ 
     (4,691) (4,385) (792) (1,036)   (845) (997)   
Any Hospitalization (%) 9% 8% 10% 12%*** 1% 4%+ 5%*** 6% -4% -2%+ 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Any Emergency Visit (%) 12% 11% 15%** 16%*** 3% 5% 14%* 11% 2% 0% 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Total Health Care Cost($) $5,972.55 $6,935.94 $5,874.09 $7,279.05 -$98.46 $343.11 $3,881.45*** $4,568.07*** -$2091.10 -$2367.87 
 (5,321) (5,050) (881) (1,199)   (1,001) (1,182)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
Notes: Estimates are for non- Medicare beneficiaries, ages 55-63, who self-report being White, African-American, or Hispanic.  
The numbers in parentheses are the number of individual in this sample category.  Estimates of number of prescriptions filled, total prescription cost, out-of-pocket cost, 
and total health care cost are based on samples with positive amounts of utilization and expenditure.  
*, **, *** Significantly different from the estimate for Whites at the alpha = 0.10, 0.05 and 0.01 level, respectively. 
+, + + Significantly different from the 2002-2005 estimate at the alpha=0.10 and 0.05 level, respectively. 
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Table 12 – Difference-in-Differences Estimates of Effects of Medicare Part D on Unadjusted Disparities in Eight Outcomes Related to Prescription Drugs between 
Whites and African-Americans, and between Whites and Hispanics 
 
Whites vs. African-Americans Whites vs. Hispanics 
Outcome Measures Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
DD t 
(p-value) 
Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
  DD t 
(p-value) 
Drug Insurance           
    Treatment (65+) 0.00 0.00 0.00 -0.01 -0.21 0.00 0.00 0.00 0.05 1.04 
    Comparison (55-63) -0.10 -0.09 0.01  (0.832) -0.27 -0.22 -0.05  (0.297) 
Any Prescriptions Filled           
    Treatment (65+) -0.01 -0.01 0.00 0.01 0.73 -0.04 -0.03 0.01 0.02 0.50 
    Comparison (55-63) -0.03 -0.04 -0.01  (0.464) -0.12 -0.13 -0.01  (0.619) 
Total Number Rx filled           
    Treatment (65+) 5.36 3.64 -1.72 0.22 0.08 -1.17 1.33 2.50 3.81 1.65 
    Comparison (55-63) 2.92 0.98 -1.94  (0.937) -3.06 -4.37 -1.31  (0.099) 
Rx Total  Spending           
    Treatment (65+) $143.65 $13.08 -$130.57 -$84.05 -0.36 -$222.41 -$169.00 -$53.41 $261.58 1.68 
    Comparison (55-63) $10.21 -$36.31 -$46.52  (0.720) -$262.43 -$577.42 -$314.99  (0.094) 
Rx Out-of-Pocket  Spending          
    Treatment (65+) -$125.49 -$151.29 -$25.80 -$0.73 -0.01 -$266.08 -$207.64 $58.44 $155.49 1.63 
    Comparison (55-63) -$25.16 -$50.23 -$25.07  (0.993) -$39.14 -$136.19 -$97.05  (0.103) 
Any Hospitalization           
    Treatment (65+) 0.02 0.02 0.00 - - -0.02 -0.02 0.00 -0.02 0.81 
    Comparison (55-63) 0.01 0.04 0.03   -0.04 -0.02 0.02  (0.417) 
Any Emergency Visit           
    Treatment (65+) 0.01 0.04 0.03 0.01 0.47 -0.01 0.00 0.01 0.03 1.09 
    Comparison (55-63) 0.03 0.05 0.02  (0.639) 0.02 0.00 -0.02  (0.275) 
Total Healthcare Cost           
    Treatment (65+) -$80.07 $421.85 $501.92 $60.35 0.05 -$468.17 $156.08 $624.25 $901.02 0.76 
    Comparison (55-63) -$98.46 $343.11 $441.57  (0.962) -$2091.10 -$2367.87 -$276.77  (0.447) 
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey.  
Notes: Estimates for the comparison and treatment groups are based on the unadjusted average from Tables 10 and 11.   
Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
Treatment group consists of Medicare beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic. 
 
 
  
5
3
 53
 
 
Table 13 – RDE Adjusted Average for the Treatment Group of Outcomes Related to Prescription Drugs, and Disparities during 2002-2005 and 2006-2009 
between Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Drug Insurance (%) 73% 94% 73% 94% 0% 0% 73% 94% 0% 0% 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Any Prescriptions Filled (%) 93% 93% 92%** 92%* -1% -1% 89%*** 90%*** -4% -3% 
     (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Total Number Rx filled (#) 29.31 31.94 35.54*** 37.16*** 6.23 5.22 29.58 35.30*** 0.27 3.36++ 
 (7,688) (6,533) (1,201 (1,423)   (1,236) (1,196)   
Rx Total  Spending ($) $2,133.65 $2,400.00 $2,357.69*** $2,477.42 $ 224.04 $77.42 $1,997.15* $2,292.00 -$136.50 -$108.00 
     (7,688) (6,533) (1,201 (1,423)   (1,236) (1,196)   
Rx Out-of-Pocket ($) $1,088.73 $726.02 $989.05*** $586.11*** -$99.68 -$139.91 $877.20*** $525.37*** -$211.53 -$200.65 
     (7,616) (6,387) (1,181) (1,374)   (1,196) (1,158)   
Any Hospitalization (%) 18% 17% 20%*** 19%*** 2% 2% 16%*** 15%*** -2% -2% 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Any Emergency Visit (%) 19% 18% 20% 22% 1%++ 4%+++ 18% 18% -1% 0% 
 (8,262) (7,004) (1,307) (1,550)   (1,374) (1,324)   
Total Health Care Cost($) $9,272.46 $9,461.67 $8,691.35* $9,930.25 -$581.11 $468.58++ $8,211.62*** $8,849.91 -$1060.84 -$611.76 
 (8,075) (6,858) (1,246) (1,482)   (1,290) (1,255)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
Notes: Estimates are for Medicare beneficiaries, ages 65 and older, who self-report being White, African-American, or Hispanic.  
The numbers in parentheses are the number of individual in this sample category.  Estimates of number of prescriptions filled, total prescription cost, out-of-pocket cost, 
and total health care cost are based on samples with positive amounts of utilization and expenditure.  
*, **, *** Significantly different from the estimate for Whites at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
+ +, + + + Significantly different from the 2002-2005 estimate at the alpha=0.05 and 0.01 level, respectively. 
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Table 14 – RDE Adjusted Average for the Comparison Group of Outcomes Related to Prescription Drugs, and Disparities during 2002-2005 and 2006-2009 
between Whites and African-Americans, and between Whites and Hispanics 
 
 Whites African-Americans Disparities Hispanics Disparities 
Outcome Measures 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 02-05 06-09 
Drug Insurance (%) 88% 90% 78%*** 81%*** -10% -9% 61%*** 68%*** -27% -22%++ 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Any Prescriptions Filled (%) 84% 83% 81%** 79%*** -3% -4% 72%*** 70%*** -12% -13% 
     (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Total Number Rx filled (#) 20.06 20.58 23.25*** 22.82*** 3.19 2.24 18.19** 16.93*** -1.87 -3.65+ 
 (4,741) (4,472) (808) (1,085)   (871) (1,024)   
Rx Total  Spending ($) $1,530.74 $1,691.55 $1,492.88 $1,663.33 -$37.86 -$28.22 $1,280.62*** $1,147.97*** -$250.12 -$543.58+++ 
     (4,741) (4,472) (808) (1,085)   (871) (1,024)   
Rx Out-of-Pocket ($) $554.89 $500.05 $528.55 $475.97* -$26.34 -$24.08 $547.39 $355.93*** -$7.50 -$144.12+++ 
     (4,691) (4,385) (792) (1,036)   (845) (997)   
Any Hospitalization (%) 9% 8% 10%** 12%*** 1% 4%+++ 5%*** 6%*** -4% -2%+++ 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Any Emergency Visit (%) 12% 11% 15%*** 16%*** 3% 5%+++ 14%*** 10% 2% -1%+++ 
 (5,663) (5,376) (1,003) (1,383)   (1,213) (1,443)   
Total Health Care Cost($) $5,751.97 $6,498.73 $5,508.21 $6,553.87 -$243.76 $55.14 $3,355.04*** $3,921.42*** -$2396.93 -$2,577.31 
 (5,321) (5,050) (881) (1,199)   (1,001) (1,182)   
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
Notes: Estimates are for non-Medicare beneficiaries, ages 55-63, who self-report being White, African-American, or Hispanic.  
The numbers in parentheses are the number of individual in this sample category.  Estimates of number of prescriptions filled, total prescription cost, and out-of-pocket cost 
are based on samples with positive amounts of utilization and expenditure.  
*, **, *** Significantly different from the estimate for Whites at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
+, + +, + + + Significantly different from the 2002-2005 estimate at the alpha=0.10, 0.05, and 0.01 level, respectively. 
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Table 15 – Difference-in-Differences Estimates of Effects of Medicare Part D on RDE Adjusted Disparities in Eight Outcomes Related to Prescription Drugs 
between Whites and African-Americans, and between Whites and Hispanics 
 
Whites vs. African-Americans Whites vs. Hispanics 
Outcome Measures Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
DD t 
(p-value) 
Difference 
2002-2005 
Difference 
2006-2009 
Difference 
over time 
  DD t 
(p-value) 
Drug Insurance           
    Treatment (65+) 0.00 0.00 0.00 -0.01 -0.38 0.00 0.00 0.00 -0.05 -1.80 
    Comparison (55-63) -0.10 -0.09 0.01  (0.705) -0.27 -0.22 0.05  (0.073) 
Any Prescriptions Filled           
    Treatment (65+) -0.01 -0.01 0.00 0.01 1.25 -0.04 -0.03 0.01 0.02 0.80 
    Comparison (55-63) -0.03 -0.04 -0.01  (0.211) -0.12 -0.13 -0.01  (0.422) 
Total Number Rx filled           
    Treatment (65+) 6.23 5.22 -1.01 -0.06 -0.03 0.27 3.36 3.09 4.87 2.69 
    Comparison (55-63) 3.19 2.24 -0.95  (0.974) -1.87 -3.65 -1.78  (0.007) 
Rx Total  Spending           
    Treatment (65+) $224.04 $77.42 -$146.62 -$156.26 -1.15 -$136.50 -$108.00 $28.50 $321.96 2.44 
    Comparison (55-63) -$37.86 -$28.22 $9.64  (0.251) -$250.12 -$543.58 -$293.46  (0.015) 
Rx Out-of-Pocket  Spending          
    Treatment (65+) -$99.68 -$139.91 -$40.23 -$42.49 -1.12 -$211.53 -$200.65 $10.88 $147.50 3.67 
    Comparison (55-63) -$26.34 -$24.08 $2.26  (0.264) -$7.50 -$144.12 -$136.62  (0.000) 
Any Hospitalization           
    Treatment (65+) 0.02 0.02 0.00 - - -0.02 -0.02 0.00 -0.02 -2.39 
    Comparison (55-63) 0.01 0.04 0.03  - -0.04 -0.02 0.02  (0.017) 
Any Emergency Visit           
    Treatment (65+) 0.01 0.04 0.03 0.01 1.55 -0.01 0.00 0.01 0.04 3.95 
    Comparison (55-63) 0.03 0.05 0.02  (0.122) 0.02 -0.01 -0.03  (0.000) 
Total Healthcare Cost           
    Treatment (65+) -$581.11 $468.58 $1,049.69 $750.79 1.39 -$1060.84 -$611.76 $449.08 $629.46 1.10 
    Comparison (55-63) -$243.76 $55.14 $298.90  (0.166) -$2396.93 -$2577.31 -$180.38  (0.271) 
 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey.  
Notes: Estimates for the comparison and treatment groups are based on the adjusted regression models reported in Appendix Tables B9-B17 and the disparity estimates from 
Tables 13 and 14.   
Comparison group consists of adults without Medicare, ages 55-63, who self-report being White, African-American, or Hispanic. 
Treatment group consists of Medicare beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic. 
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APPENDIX A1: CHARACTERISTICS OF MEDICARE BENEFICIARIES, AGES 65 AND OVER, BY RACE AND ETHNICITY IN 2002-2005 AND IN 
2006-2009 
  White Black Hispanic 
  02-05 06-09 02-05 06-09 02-05 06-09 
N  8,262 
 
7,004 
 
1,307 
 
1,550 
 
1,374 
 
1,324 
 
List of Independent Variables Description       
Need-related  
Age age at the beginning of the year 74.27 74.21 72.95*** 73.77+ 72.87** 73.75 
Female 1 if individual is female 0.57 0.57 0.61 0.63+++ 0.56 0.57 
Poor/Fair Health 1 if individual rates his/her health as poor or fair 0.20 0.20 0.35 0.34+++ 0.38 0.39+++ 
Poor/Fair Mental Health 1 if individual rates his/her mental health as poor/fair 0.07 0.07 0.14 0.16+++ 0.15 0.17+++ 
PCS physical component summary SF12 41.72 41.61 39.53 40.02++
+ 
40.61 39.83+++ 
MCS mental component summary SF12 52.47 52.93 50.73 51.10++
+ 
49.05 48.78+++ 
Function_ Index
a
 Index of Physical Limitation 7.73 7.66 10.77 10.68++
+ 
8.81 8.95++ 
Chronic_Index
b
 Index of 10 diagnosed/reported chronic conditions 2.61* 2.93 2.81*** 3.17+++ 2.46*** 2.79 
Diabetes 1 if individual diagnosed with diabetes 0.15 0.18 0.30 0.30+++ 0.30 0.32+++ 
Heart 1 if individual has any heart problem 0.33 0.37 0.27 0.31+++ 0.22*** 0.28+++ 
Asthma 1 if individual diagnosed with asthma 0.08 0.09 0.10 0.11 0.08 0.09 
Arthritis 1 if individual diagnosed with arthritis 0.53 0.58 0.53*** 0.63+++ 0.48 0.51+++ 
High Blood Pressure 1 if individual diagnosed with high blood pressure 0.60 0.66 0.77** 0.82+++ 0.62*** 0.70++ 
Stroke 1 if individual has ever had a stroke 0.10 0.12 0.11* 0.14++ 0.08 0.10 
Marital Status        
Married 1 if individual is married 0.57 0.57 0.34 0.33+++ 0.48 0.47+++ 
Education        
Less than High School 1 if individual has no high school diploma 0.21 0.17 0.44 0.43+++ 0.68 0.65+++ 
High School (omitted) 1 if individual has high school diploma 0.53 0.55 0.40 0.42+++ 0.23 0.23+++ 
College and Graduate School 1 if individual has a college or graduate degree 0.20 0.23 0.12 0.12+++ 0.08 0.09+++ 
Other Degree 1 if individual has other degrees 0.06 0.06 0.03 0.04++ 0.02 0.03+++ 
Household Income Level        
Poor or Near Poor 1 if household income < 125% FPL 0.14 0.14 0.35* 0.32+++ 0.33* 0.30+++ 
Low Income (omitted) 1 if household income is 125-199% FPL 0.19 0.17 0.27 0.24+++ 0.23 0.23+++ 
Middle Income 1 if household income is 200-399% FPL 0.31 0.31 0.23* 0.26+++ 0.26 0.27+ 
High Income 1 if household income >=400% FPL 0.36 0.38 0.15 0.18+++ 0.17 0.19+++ 
      Continued 
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  White Black Hispanic 
  02-05 06-09 02-05 06-09 02-05 06-09 
Health Insurance 
a
        
Medicaid 1 if individual has Medicaid 0.04 0.04 0.25** 0.19+++ 0.34 0.32+++ 
Private HMO Insurance 1 if individual holds private HMO insurance 0.09 0.08 0.09 0.09 0.08 0.07 
Private Non-HMO Insurance 1 if individual holds private non-HMO insurance 0.49 0.41 0.25** 0.19+++ 0.14 0.11+++ 
No Private Insurance(omitted) 1 if individual holds no private insurance 0.42 0.51 0.65 0.72+++ 0.77 0.81+++ 
Health Habits        
Exercise 1 if individual does exercise  0.51 0.50 0.37 0.38+++ 0.45 0.41+++ 
Smoker 1 if individual smokes 0.10 0.09 0.13 0.11+ 0.10* 0.07 
Attitude Toward Risk and Health Insurance 
Insurance Not Needed 1 if individual thinks health insurance is not needed 0.06 0.06 0.05 0.06 0.10* 0.07 
Insurance Not Worth Cost 1 if individual thinks health insurance is not worth the 
cost 
0.16 0.15 0.18 0.19++ 0.21** 0.17 
Location        
Northeast 1 if individual lives in Northeast 0.21 0.20 0.18 0.19 0.13 0.15++ 
Midwest 1 if individual lives in Midwest  0.24 0.25 0.20 0.15+++ 0.05 0.05+++ 
South 1 if individual lives in South 0.35 0.36 0.53 0.57+++ 0.44 0.42 
West (omitted ) 1 if individual lives in West  0.20 0.19 0.08 0.09+++ 0.38 0.38+++ 
Metropolitan Area 1 if individual lives in a statistical metropolitan area 0.76 0.78 0.86 0.85+++ 0.93 0.91+++ 
Language        
English Language 1 if language of the interview is English 1.00 1.00 1.00 1.00 0.50 0.46+++ 
Source: Data are from the household component files of the 2002-2009 Medical Expenditure Panel Survey. 
a Function-Index is an index of limitation on activities of daily living (ADLs) and instrumental activities of daily living (IADLs). 
b Chronic-Index is summed across 10 conditions: diabetes, asthma, high blood pressure, coronary heart disease, angina, heart attack, other heart disease, stroke, joint pain, and 
emphysema.   
*, **, *** Significantly different from 2006-2009 at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
 
+, ++, +++ Significantly different from Whites at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
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APPENDIX A2: CHARACTERISTICS OF THE NEAR-ELDERLY ADULTS WITHOUT MEDICARE, AGES 55-63, BY RACE AND ETHNICITY IN 2002-
2005 AND IN 2006-2009 
  White Black Hispanic 
  02-05 06-09 02-05 06-09 02-05 06-09 
N  5,663 
 
5,376 
 
1,003 
 
1,383 
 
1,213 
 
1,443 
 
List of Independent Variables Description       
Need-related        
Age age at the beginning of the year 58.62 58.74 58.54 58.43+++
+ 
58.36 58.29++
+ Female 1 if individual is female 0.52 0.51 0.58 0.55+ 0.51 0.51 
Poor/Fair Health 1 if individual rates his/her health as poor or fair 0.13 0.14 0.25 0.24+++ 0.26 0.26+++ 
Poor/Fair Mental Health 1 if individual rates his/her mental health as poor/fair  0.05 0.06 0.08 0.09+++ 0.09 0.09+++ 
PCS physical component summary SF12 48.32 48.19 44.99* 46.14+++ 45.98**
* 
47.72 
MCS mental component summary SF12 52.33 52.25 51.67 51.60 49.44* 50.37++
+ Function _Index
a
 Index of Physical Limitation 2.93 2.95 5.07 4.54+++ 3.47*** 2.23+++ 
Chronic_Index
b
 Index of 10 diagnosed/reported chronic conditions 1.77*** 1.89 2.08 2.14+++ 1.51 1.56+++ 
Diabetes 1 if individual diagnosed with diabetes 0.10*** 0.13 0.19 0.21+++ 0.18 0.22+++ 
Heart 1 if individual has any heart problem 0.15 0.17 0.12** 0.16 0.10 0.10+++ 
Asthma 1 if individual diagnosed with asthma 0.10 0.09 0.11 0.10 0.08 0.06++ 
Arthritis 1 if individual diagnosed with arthritis 0.37 0.38 0.39 0.40 0.28 0.27+++ 
High Blood Pressure 1 if individual diagnosed with high blood pressure 0.41*** 0.46 0.63 0.64+++ 0.39* 0.45 
Stroke 1 if individual has ever had a stroke 0.03 0.03 0.05 0.06++ 0.03 0.04 
Marital Status        
Married 1 if individual is married 0.73 0.71 0.49 0.46+++ 0.65* 0.60+++ 
Education        
Less than High School 1 if individual has no high school diploma 0.07*** 0.05 0.25** 0.19+++ 0.51** 0.44+++ 
High School (omitted) 1 if individual has high school diploma 0.52*** 0.48 0.48* 0.53++ 0.33 0.37+++ 
College and Graduate School 1 if individual has a college or graduate degree 0.32*** 0.36 0.21 0.20+++ 0.12 0.13+++ 
Other Degree 1 if individual has other degrees 0.08*** 0.10 0.06 0.08+ 0.04 0.06+++ 
Household Income Level        
Poor or Near Poor 1 if household income < 125% FPL 0.08 0.08 0.25 0.22+++ 0.25 0.20+++ 
Low Income (omitted) 1 if household income is 125-199% FPL 0.07 0.07 0.14 0.16+++ 0.16 0.19+++ 
Middle Income 1 if household income is 200-399% FPL 0.25 0.24 0.25* 0.30+++ 0.32 0.30+++ 
      Continued 
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  White Black Hispanic 
  02-05 06-09 02-05 06-09 02-05 06-09 
High Income 1 if household income >=400% FPL 0.61 0.62 0.36 0.32+++ 0.27 0.31+++ 
Health Insurance         
Medicaid 1 if individual has Medicaid 0.03 0.03 0.13 0.13+++ 0.12 0.09+++ 
Private HMO Insurance 1 if individual holds private HMO insurance 0.31*** 0.25 0.32** 0.25 0.30 0.27 
Private Non-HMO Insurance 1 if individual holds private non-HMO insurance 0.52*** 0.57 0.31* 0.36+++ 0.20* 0.24+++ 
No Private Insurance(omitted) 1 if individual holds no private insurance 0.16 0.18 0.37 0.39+++ 0.50 0.49+++ 
Health Habits        
Exercise 1 if individual does exercise  0.60 0.60 0.49 0.51+++ 0.48 0.50+++ 
Smoker 1 if individual smokes 0.20 0.18 0.25 0.24+++ 0.11 0.13+++ 
Attitude Toward Risk and Health Insurance 
Insurance Not Needed 1 if individual thinks health insurance is not needed 0.06 0.06 0.06 0.08 0.12 0.11+++ 
Insurance Not Worth Cost 1 if individual thinks health insurance is not worth the 
cost 
0.23 0.22 0.24 0.22 0.23 0.26++ 
Location        
Northeast 1 if individual lives in Northeast 0.20 0.20 0.16 0.17 0.19 0.16+ 
Midwest 1 if individual lives in Midwest  0.27 0.25 0.21 0.17+++ 0.07 0.08+++ 
South 1 if individual lives in South 0.34 0.34 0.55 0.57+++ 0.36 0.35 
West (omitted ) 1 if individual lives in West  0.19 0.21 0.08 0.08+++ 0.38 0.42+++ 
Metropolitan Area 1 if individual lives in a statistical metropolitan area 0.79 0.79 0.86** 0.91+++ 0.92 0.94+++ 
Language        
English Language 1 if language of the interview is English 1.00 1.00 1.00 1.00 0.52 0.47+++ 
Source: The data is from the household component file of the 2002-2009 Medical Expenditure Panel Survey. 
a Function-Index is an index of limitation on activities of daily living (ADLs) and instrumental activities of daily living (IADLs). 
b Chronic-Index is summed across 10 conditions: diabetes, asthma, high blood pressure, coronary heart disease, angina, heart attack, other heart disease, stroke, joint pain, and 
emphysema.   
*, **, *** Significantly different from 2006-2009 at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
+, ++, +++ Significantly different from Whites at the alpha = 0.10, 0.05, and 0.01 level, respectively. 
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APPENDIX B1: LOGIT REGRESSION RESULTS FOR HAVING DRUG 
INSURANCE COVERAGE: 02-09 
Explanatory Variables β SE t P > t 
treatment -0.690 0.107 -6.440 0.000 
part d 0.232 0.080 2.910 0.004 
treatment * part d 1.838 0.125 14.710 0.000 
black -1.274 0.200 -6.380 0.000 
black * treatment 0.829 0.183 4.540 0.000 
black * part d 0.064 0.166 0.380 0.701 
black * treatment * part d 0.254 0.236 1.080 0.282 
hispanic -1.172 0.206 -5.690 0.000 
hispanic * treatment 1.621 0.231 7.010 0.000 
hispanic * part d 0.381 0.167 2.280 0.023 
hispanic * treatment * part d -0.061 0.319 -0.190 0.848 
age 0.000 0.006 0.020 0.986 
female -0.429 0.046 -9.260 0.000 
poor/fair health -0.039 0.075 -0.530 0.597 
poor/fair mental health 0.066 0.082 0.800 0.426 
pcs -0.009 0.003 -3.230 0.001 
mcs -0.001 0.002 -0.290 0.773 
function_index 0.002 0.003 0.850 0.398 
chronic_index 0.126 0.037 3.440 0.001 
diabetes 0.603 0.076 7.900 0.000 
heart 0.086 0.078 1.100 0.274 
asthma 0.366 0.095 3.850 0.000 
arthritis 0.123 0.070 1.750 0.081 
High blood pressure 0.480 0.066 7.260 0.000 
stroke -0.102 0.096 -1.060 0.288 
married 0.291 0.056 5.230 0.000 
less than high school -0.228 0.062 -3.660 0.000 
college and graduate 0.147 0.073 2.010 0.045 
other degree 0.019 0.105 0.180 0.858 
poor or near poor -0.070 0.066 -1.060 0.292 
middle income 0.181 0.068 2.670 0.008 
high income 0.442 0.077 5.720 0.000 
medicaid 2.314 0.132 17.510 0.000 
private hmo 2.670 0.117 22.760 0.000 
private non-hmo 1.782 0.081 21.920 0.000 
exercise 0.002 0.047 0.050 0.961 
smoker -0.187 0.070 -2.670 0.008 
Continued 
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Explanatory Variables β SE t P > t 
insurance not needed -0.623 0.081 -7.690 0.000 
insurance not worth cost -0.436 0.056 -7.750 0.000 
northeast -0.008 0.105 -0.070 0.941 
midwest -0.154 0.087 -1.780 0.076 
south -0.166 0.077 -2.150 0.032 
metropolitan area 0.378 0.067 5.620 0.000 
english language 0.349 0.135 2.580 0.010 
black * poor health 0.575 0.165 3.480 0.001 
black * middle income 0.305 0.116 2.630 0.009 
black * private hmo 0.740 0.312 2.380 0.018 
black * private non-hmo 1.004 0.227 4.430 0.000 
black * insurance not worth cost 0.358 0.114 3.140 0.002 
hispanic * married -0.505 0.147 -3.440 0.001 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 52, 404)= 71.86  P < 0.0001 
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APPENDIX B2: LOGIT REGRESSION RESULTS FOR HAVING ANY 
PRESCRIPTIONS FILLED DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.328 0.122 2.690 0.007 
part d -0.176 0.068 -2.600 0.010 
treatment * part d -0.037 0.119 -0.310 0.753 
black -0.258 0.173 -1.500 0.135 
black * treatment -0.011 0.196 -0.060 0.954 
black * part d -0.131 0.171 -0.770 0.445 
black * treatment * part d 0.139 0.284 0.490 0.625 
hispanic -0.307 0.186 -1.650 0.101 
hispanic * treatment 0.268 0.186 1.440 0.150 
hispanic * part d -0.001 0.151 -0.010 0.995 
hispanic * treatment * part d -0.148 0.270 -0.550 0.584 
age 0.022 0.006 3.680 0.000 
female 0.573 0.048 11.860 0.000 
poor/fair health 0.099 0.097 1.020 0.307 
poor/fair mental health -0.059 0.128 -0.460 0.644 
pcs -0.040 0.004 -11.390 0.000 
mcs -0.013 0.003 -4.260 0.000 
function_index -0.001 0.005 -0.220 0.827 
chronic_index 0.179 0.045 3.970 0.000 
diabetes 1.817 0.165 11.040 0.000 
heart 0.784 0.118 6.670 0.000 
asthma 0.617 0.137 4.510 0.000 
arthritis 0.475 0.084 5.680 0.000 
High blood pressure 1.625 0.081 20.050 0.000 
stroke 0.327 0.173 1.890 0.059 
married 0.335 0.063 5.350 0.000 
less than high school -0.306 0.081 -3.760 0.000 
college and graduate 0.220 0.064 3.450 0.001 
other degree 0.221 0.106 2.100 0.037 
poor or near poor 0.171 0.097 1.760 0.079 
middle income 0.304 0.079 3.860 0.000 
high income 0.491 0.086 5.690 0.000 
medicaid 0.262 0.115 2.270 0.024 
private hmo 0.573 0.073 7.820 0.000 
private non-hmo 0.550 0.063 8.680 0.000 
exercise -0.057 0.053 -1.090 0.278 
Continued 
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Explanatory Variables β SE t P > t 
smoker -0.497 0.063 -7.850 0.000 
insurance not needed -0.704 0.078 -9.080 0.000 
insurance not worth cost -0.281 0.059 -4.770 0.000 
northeast 0.035 0.083 0.420 0.673 
midwest 0.024 0.076 0.320 0.748 
south 0.170 0.065 2.610 0.009 
metropolitan area 0.002 0.062 0.040 0.971 
english language 0.158 0.156 1.020 0.311 
black * heart -0.649 0.220 -2.960 0.003 
black * hypertension 0.346 0.149 2.320 0.021 
black * married -0.390 0.148 -2.640 0.008 
black * poor or near poor -0.470 0.170 -2.760 0.006 
hispanic * middle income -0.221 0.144 -1.540 0.125 
hispanic * high income -0.340 0.175 -1.950 0.052 
hispanic * college 0.509 0.250 2.040 0.042 
hispanic * insurance not worth cost 0.335 0.156 2.150 0.032 
intercept 0.714 0.517 1.380 0.168 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 52, 404)= 54.22 P < 0.0001 
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APPENDIX B3: GLM REGRESSION RESULTS FOR THE NUMBER OF 
PRESCRIPTIONS FILLED DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.010 0.032 0.320 0.750 
part d -0.032 0.026 -1.220 0.221 
treatment * part d 0.057 0.033 1.750 0.081 
black -0.222 0.057 -3.910 0.000 
black * treatment 0.084 0.056 1.510 0.133 
black * part d 0.011 0.061 0.170 0.861 
black * treatment * part d -0.018 0.079 -0.220 0.824 
hispanic -0.136 0.054 -2.510 0.013 
hispanic * treatment 0.039 0.061 0.650 0.517 
hispanic * part d -0.030 0.063 -0.480 0.631 
hispanic * treatment * part d 0.089 0.078 1.140 0.253 
age 0.002 0.001 1.380 0.169 
female 0.153 0.014 10.830 0.000 
poor/fair health 0.136 0.016 8.270 0.000 
poor/fair mental health 0.004 0.022 0.190 0.852 
pcs -0.012 0.001 -17.280 0.000 
mcs -0.006 0.001 -10.050 0.000 
function_index 0.004 0.001 5.410 0.000 
chronic_index 0.046 0.008 5.500 0.000 
diabetes 0.421 0.017 24.950 0.000 
heart 0.234 0.020 11.780 0.000 
asthma 0.169 0.022 7.680 0.000 
arthritis 0.051 0.018 2.910 0.004 
High blood pressure 0.403 0.016 25.410 0.000 
stroke 0.072 0.023 3.060 0.002 
married -0.020 0.015 -1.280 0.200 
less than high school 0.007 0.017 0.400 0.688 
college and graduate 0.011 0.018 0.650 0.515 
other degree 0.012 0.030 0.400 0.691 
poor or near poor 0.008 0.020 0.400 0.690 
middle income 0.011 0.017 0.600 0.546 
high income 0.008 0.019 0.400 0.689 
medicaid 0.246 0.029 8.580 0.000 
private hmo 0.037 0.024 1.550 0.122 
private non-hmo 0.040 0.018 2.220 0.027 
    Continued 
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Explanatory Variables β SE t P > t 
exercise -0.069 0.014 -5.010 0.000 
smoker -0.036 0.020 -1.820 0.070 
insurance not needed -0.190 0.031 -6.040 0.000 
insurance not worth the cost -0.108 0.016 -6.700 0.000 
northeast 0.065 0.027 2.400 0.017 
midwest 0.139 0.028 4.950 0.000 
south 0.115 0.024 4.860 0.000 
metropolitan area -0.022 0.024 -0.940 0.350 
english language 0.134 0.039 3.410 0.001 
black * female -0.117 0.038 -3.040 0.002 
black * exercise 0.118 0.033 3.570 0.000 
black * metropolitan area 0.080 0.041 1.960 0.050 
intercept 3.006 0.116 26.030 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=32278, Wald-test of null that all parameters are 0: F( 47,   409) =  188.23   P < 0.0001 
Boxcox-test to find the appropriate link function: θ =.239, SE=.004, CI=0.231-0.247 
Coefficient of dispersion:  α= .541, SE= 0.007,  CI=   0.527-0.555 
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APPENDIX B4: GLM REGRESSION RESULTS FOR THE TOTAL 
EXPENDITURE OF PRESCRIPTION DRUGS DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.081 0.039 2.100 0.036 
part d 0.042 0.040 1.050 0.293 
treatment * part d 0.019 0.054 0.350 0.729 
black -0.550 0.088 -6.280 0.000 
black * treatment 0.144 0.072 1.990 0.048 
black * part d 0.057 0.080 0.710 0.479 
black * treatment * part d -0.100 0.102 -0.970 0.330 
hispanic -0.277 0.091 -3.040 0.003 
hispanic * treatment 0.125 0.094 1.330 0.184 
hispanic * part d -0.177 0.113 -1.570 0.117 
hispanic * treatment * part d 0.138 0.131 1.050 0.294 
age -0.002 0.002 -1.280 0.200 
female 0.081 0.018 4.420 0.000 
poor/fair health 0.184 0.034 5.430 0.000 
poor/fair mental health 0.028 0.035 0.810 0.421 
pcs -0.015 0.001 -13.800 0.000 
mcs -0.007 0.001 -8.040 0.000 
function_index 0.002 0.001 1.540 0.124 
chronic_index 0.038 0.016 2.280 0.023 
diabetes 0.414 0.024 17.090 0.000 
heart 0.237 0.048 4.950 0.000 
asthma 0.306 0.078 3.920 0.000 
arthritis 0.048 0.024 1.970 0.049 
High blood pressure 0.271 0.027 10.190 0.000 
stroke 0.111 0.039 2.830 0.005 
married 0.020 0.023 0.890 0.376 
less than high school -0.066 0.027 -2.440 0.015 
college and graduate 0.054 0.027 2.000 0.046 
other degree 0.016 0.041 0.390 0.698 
poor or near poor -0.036 0.044 -0.820 0.411 
middle income 0.037 0.044 0.820 0.412 
high income 0.046 0.041 1.100 0.272 
medicaid 0.297 0.043 6.970 0.000 
private hmo 0.070 0.037 1.910 0.057 
private non-hmo 0.145 0.029 5.050 0.000 
exercise -0.082 0.025 -3.330 0.001 
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Explanatory Variables β SE t P > t 
smoker -0.084 0.028 -3.030 0.003 
insurance not needed -0.243 0.042 -5.750 0.000 
insurance not worth the cost -0.168 0.025 -6.810 0.000 
northeast 0.168 0.041 4.100 0.000 
midwest 0.140 0.037 3.820 0.000 
south 0.145 0.032 4.490 0.000 
metropolitan area 0.049 0.030 1.630 0.104 
english language 0.200 0.059 3.360 0.001 
black * diabetes 0.141 0.050 2.820 0.005 
black * high blood pressure 0.169 0.074 2.270 0.024 
black * exercise 0.161 0.050 3.230 0.001 
black * insurance not needed 0.288 0.143 2.020 0.044 
black * insurance not worth cost 0.104 0.060 1.730 0.085 
hispanic * diabetes 0.140 0.065 2.170 0.031 
hispanic * private hmo 0.279 0.117 2.390 0.017 
hispanic * private non-hmo 0.117 0.077 1.530 0.128 
intercept 7.607 0.185 41.150 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic 
with a positive drug expenditure.  
n=32278, Wald-test of null that all parameters are 0: F (52,   404) =   96.67  p < 0.0001 
Boxcox-test to find the appropriate link function: θ=0.214, SE=0.003, CI=0.208-0.220 
Modified Park-test to find the appropriate distribution family: λ=1.839, 
SE=0.348, CI=1.154-2.524 
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APPENDIX B5: GLM REGRESSION RESULTS FOR THE OUT-OF-POCKET 
COST OF PRESCRIPTION DRUGS DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.282 0.042 6.700 0.000 
part d -0.172 0.040 -4.330 0.000 
treatment * part d -0.313 0.050 -6.270 0.000 
black -0.195 0.078 -2.490 0.013 
black * treatment 0.100 0.076 1.320 0.188 
black * part d 0.042 0.084 0.500 0.616 
black * treatment * part d -0.171 0.110 -1.550 0.121 
hispanic -0.059 0.095 -0.620 0.536 
hispanic * treatment -0.131 0.113 -1.160 0.247 
hispanic * part d -0.321 0.101 -3.170 0.002 
hispanic * treatment * part d 0.167 0.150 1.110 0.267 
age 0.002 0.002 1.250 0.212 
female 0.207 0.020 10.110 0.000 
poor/fair health 0.139 0.030 4.580 0.000 
poor/fair mental health -0.001 0.036 -0.010 0.989 
pcs -0.013 0.001 -11.580 0.000 
mcs -0.006 0.001 -5.330 0.000 
function_index 0.002 0.001 1.930 0.054 
chronic_index 0.036 0.014 2.600 0.010 
diabetes 0.389 0.028 13.700 0.000 
heart 0.183 0.031 5.890 0.000 
asthma 0.166 0.037 4.520 0.000 
arthritis 0.031 0.030 1.050 0.293 
High blood pressure 0.344 0.027 12.840 0.000 
stroke 0.114 0.036 3.200 0.001 
married -0.003 0.027 -0.120 0.901 
less than high school -0.034 0.025 -1.340 0.180 
college and graduate 0.084 0.029 2.860 0.004 
other degree 0.054 0.050 1.080 0.280 
poor or near poor -0.020 0.033 -0.600 0.548 
middle income 0.018 0.032 0.580 0.565 
high income 0.017 0.030 0.560 0.576 
medicaid -0.784 0.070 -11.160 0.000 
private hmo -0.293 0.035 -8.450 0.000 
private non-hmo -0.114 0.030 -3.760 0.000 
exercise -0.068 0.022 -3.120 0.002 
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Explanatory Variables β SE t P > t 
smoker -0.073 0.028 -2.580 0.010 
insurance not needed -0.178 0.048 -3.720 0.000 
insurance not worth the cost -0.090 0.024 -3.820 0.000 
northeast 0.091 0.041 2.230 0.027 
midwest 0.114 0.040 2.840 0.005 
south 0.189 0.037 5.120 0.000 
metropolitan area -0.065 0.036 -1.820 0.070 
english language -0.053 0.060 -0.870 0.382 
black * heart -0.108 0.055 -1.960 0.050 
black * artheritis -0.149 0.066 -2.280 0.023 
black * exercise 0.103 0.049 2.090 0.038 
hispanic * diabetes 0.205 0.088 2.320 0.021 
hispanic * asthma -0.236 0.098 -2.410 0.016 
intercept 6.715 0.192 34.890 0.000 
Source: Data are from the household component file of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic 
with a positive out-of-pocket drug expenditure.  
n=31658, Wald-test of null that all parameters are 0: F (49,   407) =   84.83  p < 0.0001 
Boxcox-test to find the appropriate link function: θ=0.144   , SE=0.003, CI=0.138- 0.150 
Modified Park-test to find the appropriate distribution family: λ=1.450, 
SE=0.087, CI=1.275-1.617 
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APPENDIX B6: LOGIT REGRESSION RESULTS FOR HAVING ANY 
HOSPITALIZATIONS DURING THE PAST YEAR:02-09 
Explanatory Variables β SE t P > t 
treatment 0.087 0.086 1.010 0.313 
part d -0.202 0.077 -2.630 0.009 
treatment * part d 0.095 0.093 1.020 0.310 
black -0.090 0.175 -0.510 0.607 
black * treatment 0.114 0.201 0.570 0.572 
black * part d 0.462 0.204 2.270 0.024 
black * treatment * part d -0.433 0.248 -1.750 0.081 
hispanic -0.373 0.220 -1.690 0.091 
hispanic * treatment 0.507 0.198 2.560 0.011 
hispanic * part d 0.448 0.205 2.180 0.029 
hispanic * treatment * part d -0.508 0.266 -1.910 0.056 
age 0.015 0.004 3.950 0.000 
female -0.112 0.043 -2.600 0.010 
poor/fair health 0.208 0.055 3.770 0.000 
poor/fair mental health -0.227 0.066 -3.430 0.001 
pcs -0.037 0.002 -15.750 0.000 
mcs -0.012 0.002 -5.960 0.000 
function_index 0.002 0.002 0.840 0.399 
chronic_index 0.009 0.027 0.340 0.734 
diabetes 0.133 0.055 2.430 0.015 
heart 0.638 0.060 10.570 0.000 
asthma 0.165 0.067 2.460 0.014 
arthritis 0.062 0.056 1.110 0.269 
High blood pressure 0.167 0.050 3.360 0.001 
stroke 0.402 0.081 4.970 0.000 
married -0.084 0.045 -1.860 0.063 
less than high school -0.034 0.060 -0.570 0.568 
college and graduate -0.023 0.058 -0.400 0.688 
other degree 0.137 0.084 1.630 0.103 
poor or near poor -0.071 0.065 -1.100 0.271 
middle income -0.066 0.059 -1.120 0.265 
high income -0.041 0.065 -0.630 0.530 
medicaid 0.098 0.070 1.380 0.167 
private hmo 0.035 0.071 0.490 0.623 
private non-hmo 0.051 0.048 1.070 0.283 
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Explanatory Variables β SE t P > t 
exercise -0.156 0.043 -3.630 0.000 
smoker -0.075 0.061 -1.230 0.218 
insurance not needed -0.217 0.108 -2.020 0.044 
insurance not worth the cost -0.273 0.059 -4.630 0.000 
northeast 0.074 0.062 1.200 0.231 
midwest 0.174 0.061 2.870 0.004 
south 0.159 0.058 2.730 0.007 
metropolitan area -0.011 0.047 -0.230 0.816 
english language -0.070 0.112 -0.620 0.533 
black * arthritis -0.149 0.116 -1.280 0.200 
black * college 0.420 0.142 2.950 0.003 
black * private hmo -0.366 0.199 -1.840 0.066 
black * insurance not needed 0.521 0.236 2.200 0.028 
hispanic * poor health -0.183 0.115 -1.590 0.112 
hispanic * private hmo 0.284 0.184 1.550 0.123 
Hispanic * insurance not worth cost 0.217 0.139 1.560 0.120 
Hispanic * metropolitan area -0.343 0.173 -1.980 0.048 
intercept -1.017 0.363 -2.800 0.005 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 52, 404)= 49.87  P < 0.0001 
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APPENDIX B7: LOGIT REGRESSION RESULTS FOR HAVING ANY 
EMERGENCY DEPARTMENT VISITS DURING THE PAST YEAR:02-09 
Explanatory Variables β SE t P > t 
treatment 0.047 0.087 0.540 0.588 
part d -0.133 0.075 -1.760 0.078 
treatment * part d -0.003 0.092 -0.040 0.972 
black -0.121 0.161 -0.750 0.452 
black * treatment -0.159 0.167 -0.950 0.340 
black * part d 0.236 0.172 1.370 0.173 
black * treatment * part d 0.008 0.210 0.040 0.969 
hispanic 0.057 0.124 0.460 0.645 
hispanic * treatment -0.181 0.166 -1.090 0.278 
hispanic * part d -0.134 0.154 -0.870 0.384 
hispanic * treatment * part d 0.150 0.225 0.670 0.505 
age 0.009 0.004 2.450 0.015 
female 0.094 0.041 2.310 0.021 
poor/fair health 0.132 0.049 2.680 0.008 
poor/fair mental health -0.127 0.065 -1.950 0.052 
pcs -0.022 0.002 -10.960 0.000 
mcs -0.014 0.002 -7.750 0.000 
function_index 0.002 0.002 1.060 0.290 
chronic_index 0.057 0.022 2.570 0.011 
diabetes 0.008 0.052 0.150 0.880 
heart 0.457 0.054 8.530 0.000 
asthma 0.197 0.060 3.280 0.001 
arthritis -0.070 0.052 -1.350 0.178 
High blood pressure 0.036 0.047 0.770 0.443 
stroke 0.389 0.071 5.440 0.000 
married -0.074 0.043 -1.730 0.084 
less than high school 0.037 0.051 0.730 0.465 
college and graduate -0.029 0.057 -0.500 0.617 
other degree 0.020 0.076 0.270 0.791 
poor or near poor -0.053 0.056 -0.940 0.347 
middle income -0.081 0.052 -1.570 0.117 
high income -0.094 0.057 -1.650 0.099 
medicaid 0.120 0.068 1.760 0.080 
private hmo 0.060 0.062 0.970 0.333 
private non-hmo -0.002 0.047 -0.040 0.969 
exercise -0.137 0.040 -3.380 0.001 
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Explanatory Variables β SE t P > t 
smoker 0.020 0.053 0.380 0.705 
insurance not needed -0.138 0.091 -1.520 0.130 
insurance not worth cost -0.133 0.045 -2.940 0.003 
northeast 0.139 0.060 2.310 0.021 
mid west 0.191 0.061 3.130 0.002 
south 0.014 0.055 0.250 0.800 
metropolitan area 0.025 0.052 0.480 0.633 
english language 0.281 0.100 2.820 0.005 
black * female 0.200 0.095 2.100 0.036 
black * poor health -0.184 0.099 -1.860 0.063 
black * south 0.251 0.099 2.540 0.012 
hispanic * asthma 0.288 0.175 1.640 0.101 
hispanic * exercise 0.283 0.097 2.910 0.004 
intercept -1.208 0.325 -3.720 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 49, 407)= 36.72  P < 0.0001 
  
 
74 
 
 
 
APPENDIX B8: GLM REGRESSION RESULTS FOR THE TOTAL HEALTH 
CARE COST DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.035 0.044 0.790 0.430 
part d 0.073 0.040 1.810 0.071 
treatment * part d -0.105 0.049 -2.150 0.032 
black -0.330 0.114 -2.900 0.004 
black * treatment 0.036 0.108 0.340 0.737 
black * part d 0.060 0.124 0.490 0.628 
black * treatment * part d 0.083 0.148 0.570 0.572 
hispanic -0.725 0.100 -7.220 0.000 
hispanic * treatment 0.490 0.112 4.370 0.000 
hispanic * part d 0.160 0.099 1.610 0.108 
hispanic * treatment * part d -0.142 0.143 -0.990 0.322 
age 0.005 0.002 2.370 0.018 
female -0.026 0.023 -1.150 0.251 
poor/fair health 0.186 0.032 5.740 0.000 
poor/fair mental health -0.068 0.040 -1.690 0.091 
pcs -0.026 0.001 -21.570 0.000 
mcs -0.008 0.001 -7.620 0.000 
function_index 0.006 0.001 4.460 0.000 
chronic_index 0.031 0.015 2.120 0.035 
diabetes 0.159 0.032 4.930 0.000 
heart 0.391 0.035 11.100 0.000 
asthma 0.121 0.046 2.640 0.009 
arthritis 0.070 0.028 2.470 0.014 
High blood pressure 0.129 0.028 4.600 0.000 
stroke 0.107 0.040 2.700 0.007 
married -0.017 0.023 -0.760 0.445 
less than high school -0.116 0.029 -3.950 0.000 
college and graduate 0.103 0.028 3.700 0.000 
other degree 0.085 0.045 1.870 0.062 
poor or near poor -0.028 0.037 -0.770 0.441 
middle income 0.016 0.034 0.450 0.650 
high income 0.098 0.036 2.740 0.006 
medicaid 0.119 0.047 2.540 0.011 
private hmo 0.071 0.036 1.970 0.049 
private non-hmo 0.145 0.028 5.250 0.000 
exercise -0.060 0.024 -2.540 0.011 
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Explanatory Variables β SE t P > t 
smoker -0.122 0.038 -3.210 0.001 
insurance not needed -0.214 0.050 -4.260 0.000 
insurance not worth the cost -0.218 0.025 -8.890 0.000 
northeast 0.058 0.028 2.050 0.041 
midwest 0.137 0.031 4.390 0.000 
south 0.029 0.025 1.160 0.245 
metropolitan area 0.086 0.024 3.530 0.000 
english language -0.007 0.070 -0.100 0.920 
black * female -0.119 0.078 -1.540 0.124 
black * poor health 0.134 0.076 1.770 0.077 
black * diabetes 0.151 0.075 2.000 0.046 
black * stroke 0.193 0.081 2.390 0.017 
black * non-hmo private insurance 0.213 0.082 2.600 0.010 
black * northeast 0.274 0.116 2.360 0.019 
hispanic * function_index 0.004 0.002 1.830 0.067 
hispanic * high blood pressure  -0.108 0.071 -1.530 0.126 
hispanic * medicaid 0.294 0.109 2.710 0.007 
hispanic * private hmo 0.339 0.090 3.770 0.000 
hispanic * non-hmo private insurance 0.351 0.105 3.330 0.001 
intercept 9.475 0.190 49.880 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic 
with a positive drug expenditure.  
n=34840, Wald-test of null that all parameters are 0: : F( 55,   401) =   93.13  p < .0001 
Boxcox-test to find the appropriate link function: θ=0.088, SE=0.003, CI=0.083-0.094 
Modified Park-test to find the appropriate distribution family: λ=1.802, 
SE=0.090, CI=1.626-1.978 
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APPENDIX B9: RDE LOGIT REGRESSION RESULTS FOR HAVING DRUG 
INSURANCE COVERAGE: 02-09 
Explanatory Variables β SE t P > t 
treatment -0.655 0.107 -6.100 0.000 
part d 0.238 0.080 2.960 0.003 
treatment * part d 1.861 0.127 14.700 0.000 
black -0.537 0.127 -4.240 0.000 
black * treatment 0.623 0.159 3.920 0.000 
black * part d 0.021 0.152 0.140 0.890 
black * treatment * part d 0.128 0.231 0.550 0.580 
hispanic -0.945 0.135 -7.010 0.000 
hispanic * treatment 1.381 0.197 7.010 0.000 
hispanic * part d 0.335 0.157 2.130 0.034 
hispanic * treatment * part d -0.105 0.309 -0.340 0.735 
age 0.000 0.006 0.010 0.994 
female -0.423 0.046 -9.160 0.000 
poor/fair health 0.025 0.071 0.350 0.730 
poor/fair mental health 0.066 0.082 0.810 0.419 
pcs -0.009 0.003 -3.060 0.002 
mcs 0.000 0.002 -0.160 0.871 
function_index 0.003 0.003 1.000 0.317 
chronic_index 0.125 0.036 3.450 0.001 
diabetes 0.583 0.075 7.810 0.000 
heart 0.085 0.078 1.090 0.278 
asthma 0.380 0.095 4.000 0.000 
arthritis 0.125 0.070 1.780 0.076 
High blood pressure 0.480 0.066 7.320 0.000 
stroke -0.096 0.096 -1.000 0.320 
married 0.247 0.052 4.730 0.000 
less than high school -0.239 0.061 -3.900 0.000 
college and graduate 0.150 0.073 2.050 0.041 
other degree 0.027 0.105 0.250 0.801 
poor or near poor -0.083 0.064 -1.290 0.198 
middle income 0.212 0.066 3.230 0.001 
high income 0.460 0.077 5.980 0.000 
medicaid 2.254 0.130 17.340 0.000 
private hmo 2.829 0.102 27.740 0.000 
private non-hmo 1.908 0.075 25.430 0.000 
exercise 0.005 0.046 0.100 0.921 
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Explanatory Variables β SE t P > t 
smoker -0.183 0.070 -2.630 0.009 
Insurance not needed -0.617 0.080 -7.690 0.000 
insurance not worth cost -0.389 0.052 -7.540 0.000 
northeast -0.004 0.105 -0.030 0.973 
midwest -0.147 0.087 -1.700 0.091 
south -0.159 0.078 -2.050 0.041 
metropolitan area 0.376 0.068 5.550 0.000 
english language 0.480 0.123 3.900 0.000 
intercept -0.399 0.449 -0.890 0.375 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 44, 412)= 77.00  P < 0.0001 
  
 
 
 
 
 
78 
 
 
 
APPENDIX B10: RDE LOGIT REGRESSION RESULTS FOR HAVING ANY 
PRESCRIPTIONS FILLED DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.329 0.121 2.710 0.007 
part d -0.177 0.068 -2.620 0.009 
treatment * part d -0.037 0.119 -0.310 0.754 
black -0.493 0.130 -3.780 0.000 
black * treatment -0.035 0.190 -0.180 0.854 
black * part d -0.086 0.168 -0.510 0.609 
black * treatment * part d 0.141 0.279 0.510 0.612 
hispanic -0.346 0.142 -2.440 0.015 
hispanic * treatment 0.276 0.189 1.460 0.144 
hispanic * part d 0.002 0.157 0.010 0.992 
hispanic * treatment * part d -0.171 0.276 -0.620 0.537 
age 0.022 0.006 3.670 0.000 
female 0.574 0.048 11.880 0.000 
poor/fair health 0.103 0.097 1.070 0.285 
poor/fair mental health -0.051 0.127 -0.400 0.690 
pcs -0.040 0.004 -11.370 0.000 
mcs -0.012 0.003 -4.140 0.000 
function_index -0.001 0.005 -0.250 0.805 
chronic_index 0.181 0.045 4.020 0.000 
diabetes 1.809 0.164 11.020 0.000 
heart 0.732 0.113 6.500 0.000 
asthma 0.610 0.137 4.470 0.000 
arthritis 0.473 0.083 5.660 0.000 
High blood pressure 1.660 0.077 21.470 0.000 
stroke 0.318 0.172 1.840 0.066 
married 0.304 0.059 5.130 0.000 
less than high school -0.318 0.081 -3.950 0.000 
college and graduate 0.243 0.062 3.920 0.000 
other degree 0.219 0.105 2.080 0.038 
poor or near poor 0.113 0.092 1.230 0.218 
middle income 0.272 0.076 3.580 0.000 
high income 0.456 0.084 5.410 0.000 
medicaid 0.265 0.116 2.290 0.023 
private hmo 0.570 0.073 7.800 0.000 
private non-hmo 0.549 0.063 8.650 0.000 
exercise -0.057 0.053 -1.070 0.283 
Continued 
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Explanatory Variables β SE t P > t 
smoker -0.494 0.063 -7.820 0.000 
insurance not needed -0.707 0.077 -9.120 0.000 
insurance not worth the cost -0.249 0.056 -4.430 0.000 
northeast 0.041 0.083 0.490 0.621 
midwest 0.032 0.076 0.420 0.678 
south 0.179 0.065 2.770 0.006 
metropolitan area 0.006 0.062 0.100 0.917 
english language 0.096 0.147 0.650 0.513 
intercept 0.778 0.509 1.530 0.127 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 44, 412)= 63.08 P < 0.0001 
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APPENDIX B11: RDE GLM REGRESSION RESULTS FOR THE NUMBER OF 
PRESCRIPTIONS FILLED DURING THE PAST YEAR:02-09 
Explanatory Variables β SE t P > t 
treatment 0.012 0.032 0.380 0.705 
part d -0.031 0.026 -1.210 0.226 
treatment * part d 0.057 0.033 1.750 0.081 
black -0.163 0.045 -3.640 0.000 
black * treatment 0.067 0.057 1.180 0.237 
black * part d 0.021 0.062 0.340 0.731 
black * treatment * part d -0.022 0.080 -0.280 0.781 
hispanic -0.136 0.054 -2.510 0.013 
hispanic * treatment 0.040 0.061 0.660 0.511 
hispanic * part d -0.031 0.063 -0.500 0.618 
hispanic * treatment * part d 0.090 0.078 1.160 0.248 
age 0.002 0.001 1.360 0.176 
female 0.143 0.014 10.610 0.000 
poor/fair health 0.135 0.017 8.170 0.000 
poor/fair mental health 0.004 0.022 0.160 0.869 
pcs -0.012 0.001 -17.350 0.000 
mcs -0.006 0.001 -10.120 0.000 
function_index 0.004 0.001 5.390 0.000 
chronic_index 0.046 0.008 5.520 0.000 
diabetes 0.420 0.017 24.920 0.000 
heart 0.233 0.020 11.700 0.000 
asthma 0.168 0.022 7.610 0.000 
arthritis 0.050 0.018 2.820 0.005 
High blood pressure 0.402 0.016 25.390 0.000 
stroke 0.071 0.024 3.040 0.003 
married -0.020 0.015 -1.300 0.196 
less than high school 0.006 0.017 0.340 0.736 
college and graduate 0.009 0.018 0.540 0.591 
other degree 0.012 0.030 0.400 0.692 
poor or near poor 0.007 0.020 0.350 0.728 
middle income 0.010 0.017 0.590 0.556 
high income 0.007 0.019 0.370 0.711 
medicaid 0.241 0.029 8.380 0.000 
private hmo 0.038 0.024 1.590 0.114 
private non-hmo 0.040 0.018 2.220 0.027 
exercise -0.059 0.013 -4.500 0.000 
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Explanatory Variables β SE t P > t 
smoker -0.035 0.020 -1.720 0.086 
Insurance not needed -0.191 0.031 -6.090 0.000 
insurance not worth cost -0.108 0.016 -6.730 0.000 
northeast 0.065 0.027 2.420 0.016 
midwest 0.139 0.028 4.980 0.000 
south 0.114 0.024 4.830 0.000 
methropolitan area -0.017 0.023 -0.770 0.441 
english language 0.132 0.039 3.370 0.001 
intercept 3.012 0.115 26.120 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=32278, Wald-test of null that all parameters are 0: F( 44, 412) =  202.19   P < 0.0001 
Boxcox-test to find the appropriate link function: θ =.240, SE=.004, CI=0.232-0.248 
Coefficient of dispersion:  α= .542, SE= 0.007,  CI=   0.529-0.556 
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APPENDIX B12: RDE GLM REGRESSION RESULTS FOR THE TOTAL 
EXPENDITURE OF PRESCRIPTION DRUGS DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.087 0.039 2.250 0.025 
part d 0.042 0.040 1.040 0.300 
treatment * part d 0.018 0.054 0.330 0.744 
black -0.274 0.057 -4.840 0.000 
black * treatment 0.139 0.074 1.880 0.061 
black * part d 0.065 0.081 0.800 0.424 
black * treatment * part d -0.078 0.106 -0.730 0.463 
hispanic -0.102 0.073 -1.380 0.167 
hispanic * treatment 0.045 0.089 0.510 0.612 
hispanic * part d -0.159 0.116 -1.370 0.172 
hispanic * treatment * part d 0.127 0.134 0.950 0.341 
age -0.002 0.002 -1.340 0.180 
female 0.083 0.019 4.490 0.000 
poor/fair health 0.183 0.034 5.380 0.000 
poor/fair mental health 0.030 0.035 0.840 0.401 
pcs -0.015 0.001 -13.750 0.000 
mcs -0.007 0.001 -7.940 0.000 
function_index 0.002 0.001 1.510 0.132 
chronic_index 0.036 0.017 2.190 0.029 
diabetes 0.445 0.023 19.760 0.000 
heart 0.239 0.049 4.930 0.000 
asthma 0.306 0.079 3.870 0.000 
arthritis 0.050 0.024 2.050 0.041 
High blood pressure 0.280 0.026 10.940 0.000 
stroke 0.113 0.039 2.880 0.004 
married 0.020 0.023 0.880 0.382 
less than high school -0.069 0.027 -2.510 0.012 
college and graduate 0.053 0.027 1.950 0.052 
other degree 0.016 0.042 0.380 0.703 
poor or near poor -0.037 0.045 -0.820 0.413 
middle income 0.038 0.045 0.860 0.392 
high income 0.046 0.042 1.100 0.273 
medicaid 0.291 0.043 6.840 0.000 
private hmo 0.087 0.035 2.480 0.014 
private non-hmo 0.152 0.028 5.450 0.000 
exercise -0.067 0.023 -2.920 0.004 
    Continued 
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Explanatory Variables β SE t P > t 
smoker -0.081 0.028 -2.940 0.003 
insurance not needed -0.218 0.040 -5.390 0.000 
insurance not worth cost -0.158 0.024 -6.720 0.000 
northeast 0.169 0.041 4.070 0.000 
midwest 0.138 0.037 3.780 0.000 
south 0.143 0.032 4.410 0.000 
metropolitan area 0.049 0.030 1.620 0.107 
english language 0.238 0.058 4.120 0.000 
intercept 7.547 0.185 40.820 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic 
with a positive drug expenditure.  
n=32278, Wald-test of null that all parameters are 0: F (44, 412) =   108.75  p < 0.0001 
Boxcox-test to find the appropriate link function: θ=0.214, SE=0.003, CI=0.208-0.220 
Modified Park-test to find the appropriate distribution family: λ=1.800, 
SE=0.337, CI=1.136-2.459 
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APPENDIX B13: RDE GLM REGRESSION RESULTS FOR THE OUT-OF-
POCKET COST OF PRESCRIPTION DRUGS DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.286 0.042 6.800 0.000 
part d -0.173 0.040 -4.370 0.000 
treatment * part d -0.312 0.050 -6.270 0.000 
black -0.226 0.065 -3.450 0.001 
black * treatment 0.051 0.079 0.650 0.519 
black * part d 0.041 0.085 0.490 0.626 
black * treatment * part d -0.175 0.112 -1.560 0.120 
hispanic -0.031 0.089 -0.350 0.727 
hispanic * treatment -0.133 0.111 -1.200 0.229 
hispanic * part d -0.297 0.106 -2.810 0.005 
hispanic * treatment * part d 0.161 0.151 1.070 0.286 
age 0.002 0.002 1.220 0.224 
female 0.204 0.021 9.900 0.000 
poor/fair health 0.139 0.031 4.540 0.000 
poor/fair mental health -0.005 0.037 -0.140 0.887 
pcs -0.013 0.001 -11.530 0.000 
mcs -0.006 0.001 -5.330 0.000 
function_index 0.002 0.001 1.800 0.072 
chronic_index 0.036 0.014 2.550 0.011 
diabetes 0.410 0.027 14.940 0.000 
heart 0.175 0.030 5.770 0.000 
asthma 0.150 0.036 4.190 0.000 
arthritis 0.019 0.029 0.650 0.516 
High blood pressure 0.345 0.027 12.830 0.000 
stroke 0.112 0.036 3.130 0.002 
married -0.004 0.027 -0.150 0.880 
less than high school -0.035 0.025 -1.380 0.167 
college and graduate 0.083 0.029 2.830 0.005 
other degree 0.053 0.050 1.070 0.285 
poor or near poor -0.021 0.034 -0.620 0.535 
middle income 0.018 0.032 0.570 0.571 
high income 0.015 0.030 0.490 0.623 
medicaid -0.788 0.070 -11.290 0.000 
private hmo -0.293 0.035 -8.460 0.000 
private non-hmo -0.114 0.030 -3.740 0.000 
exercise -0.059 0.021 -2.850 0.005 
    Continued 
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Explanatory Variables β SE t P > t 
smoker -0.072 0.028 -2.540 0.011 
insurance not needed -0.177 0.048 -3.670 0.000 
insurance not worth the cost -0.090 0.024 -3.790 0.000 
northeast 0.089 0.041 2.160 0.031 
midwest 0.111 0.040 2.780 0.006 
south 0.185 0.037 5.030 0.000 
metropolitan area -0.065 0.036 -1.790 0.075 
english language -0.066 0.062 -1.070 0.285 
intercept 6.746 0.195 34.650 0.000 
Source: Data are from the household component file of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic 
with a positive out-of-pocket drug expenditure.  
n=31658, Wald-test of null that all parameters are 0: F (44,   412) =   92.70  p < 0.0001 
Boxcox-test to find the appropriate link function: θ=0.144, SE=0.003, CI=0.138-0.150 
Modified Park-test to find the appropriate distribution family: λ=1.440, 
SE=0.088, CI=1.260-1.605 
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APPENDIX B14: RDE LOGIT REGRESSION RESULTS FOR HAVING ANY 
HOSPITALIZATIONS DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.091 0.085 1.080 0.281 
part d -0.204 0.077 -2.650 0.008 
treatment * part d 0.096 0.093 1.040 0.299 
black -0.140 0.152 -0.920 0.358 
black * treatment 0.122 0.195 0.620 0.533 
black * part d 0.489 0.202 2.420 0.016 
black * treatment * part d -0.463 0.248 -1.870 0.062 
hispanic -0.617 0.146 -4.240 0.000 
hispanic * treatment 0.421 0.191 2.200 0.028 
hispanic * part d 0.441 0.206 2.150 0.032 
hispanic * treatment * part d -0.506 0.269 -1.880 0.060 
age 0.015 0.004 3.930 0.000 
female -0.111 0.043 -2.570 0.010 
poor/fair health 0.197 0.053 3.690 0.000 
poor/fair mental health -0.231 0.066 -3.470 0.001 
pcs -0.037 0.002 -15.770 0.000 
mcs -0.012 0.002 -5.970 0.000 
function_index 0.002 0.002 0.790 0.432 
chronic_index 0.010 0.027 0.360 0.720 
diabetes 0.132 0.055 2.420 0.016 
heart 0.638 0.060 10.560 0.000 
asthma 0.163 0.067 2.430 0.015 
arthritis 0.047 0.055 0.850 0.396 
High blood pressure 0.166 0.050 3.340 0.001 
stroke 0.402 0.081 4.980 0.000 
married -0.085 0.045 -1.890 0.059 
less than high school -0.039 0.060 -0.640 0.521 
college and graduate 0.006 0.055 0.110 0.914 
other degree 0.139 0.084 1.650 0.100 
poor or near poor -0.075 0.065 -1.150 0.251 
middle income -0.066 0.059 -1.110 0.266 
high income -0.042 0.065 -0.660 0.512 
medicaid 0.086 0.069 1.240 0.216 
private hmo 0.021 0.064 0.320 0.747 
private non-hmo 0.053 0.048 1.110 0.267 
exercise -0.158 0.043 -3.690 0.000 
    Continued 
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Explanatory Variables β SE t P > t 
smoker -0.072 0.061 -1.180 0.239 
insurance not needed -0.152 0.096 -1.580 0.116 
insurance not worth cost -0.258 0.056 -4.640 0.000 
northeast 0.075 0.062 1.210 0.225 
midwest 0.174 0.060 2.880 0.004 
south 0.160 0.058 2.750 0.006 
metropolitan area -0.021 0.046 -0.470 0.639 
english language -0.049 0.112 -0.440 0.664 
intercept -1.017 0.364 -2.790 0.005 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 44, 412)= 57.86  P < 0.0001 
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APPENDIX B15: RDE LOGIT REGRESSION RESULTS FOR HAVING ANY 
EMERGENCY DEPARTMENT VISITS DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.050 0.087 0.580 0.565 
part d -0.132 0.075 -1.750 0.080 
treatment * part d -0.004 0.092 -0.040 0.967 
black 0.075 0.138 0.540 0.589 
black * treatment -0.165 0.170 -0.970 0.332 
black * part d 0.241 0.175 1.380 0.168 
black * treatment * part d 0.014 0.212 0.070 0.946 
hispanic 0.234 0.118 1.980 0.049 
hispanic * treatment -0.200 0.166 -1.200 0.231 
hispanic * part d -0.132 0.153 -0.860 0.390 
hispanic * treatment * part d 0.142 0.222 0.640 0.524 
age 0.009 0.004 2.430 0.015 
female 0.110 0.039 2.860 0.004 
poor/fair health 0.111 0.047 2.380 0.018 
poor/fair mental health -0.130 0.065 -1.990 0.047 
pcs -0.022 0.002 -10.960 0.000 
mcs -0.014 0.002 -7.720 0.000 
function_index 0.002 0.002 1.090 0.276 
chronic_index 0.059 0.022 2.640 0.009 
diabetes 0.007 0.052 0.130 0.898 
heart 0.455 0.054 8.480 0.000 
asthma 0.213 0.058 3.700 0.000 
arthritis -0.069 0.052 -1.340 0.180 
High blood pressure 0.036 0.046 0.770 0.444 
stroke 0.388 0.071 5.430 0.000 
married -0.078 0.043 -1.830 0.068 
less than high school 0.035 0.051 0.700 0.486 
college and graduate -0.028 0.057 -0.490 0.625 
other degree 0.020 0.076 0.260 0.792 
poor or near poor -0.054 0.056 -0.960 0.339 
middle income -0.080 0.052 -1.550 0.121 
high income -0.094 0.056 -1.660 0.097 
medicaid 0.114 0.068 1.670 0.096 
private hmo 0.066 0.062 1.060 0.288 
private non-hmo 0.000 0.047 0.000 0.998 
exercise -0.119 0.039 -3.090 0.002 
    Continued 
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Explanatory Variables β SE t P > t 
smoker 0.016 0.053 0.310 0.759 
insurance not needed -0.138 0.091 -1.520 0.129 
insurance not worth the cost -0.133 0.045 -2.930 0.004 
northeast 0.134 0.060 2.240 0.026 
mid west 0.186 0.061 3.040 0.002 
south 0.038 0.054 0.710 0.478 
metropolitan area 0.018 0.052 0.350 0.726 
english language 0.298 0.099 3.020 0.003 
intercept -1.242 0.324 -3.830 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic.   
n=36,902, Wald-test of null that all parameters are 0: F( 44, 412)= 40.53  P < 0.0001 
  
 
90 
 
 
 
APPENDIX B16: RDE GLM REGRESSION RESULTS FOR THE TOTAL HEALTH 
CARE COST DURING THE PAST YEAR: 02-09 
Explanatory Variables β SE t P > t 
treatment 0.039 0.044 0.870 0.386 
part d 0.071 0.040 1.790 0.075 
treatment * part d -0.101 0.049 -2.060 0.040 
black -0.196 0.090 -2.190 0.029 
black * treatment 0.043 0.109 0.390 0.695 
black * part d 0.119 0.146 0.820 0.415 
black * treatment * part d 0.038 0.168 0.230 0.820 
hispanic -0.481 0.075 -6.390 0.000 
hispanic * treatment 0.411 0.109 3.790 0.000 
hispanic * part d 0.143 0.103 1.390 0.166 
hispanic * treatment * part d -0.147 0.149 -0.990 0.324 
age 0.005 0.002 2.440 0.015 
female -0.037 0.022 -1.660 0.098 
poor/fair health 0.201 0.033 6.070 0.000 
poor/fair mental health -0.069 0.040 -1.750 0.081 
pcs -0.026 0.001 -21.160 0.000 
mcs -0.008 0.001 -7.390 0.000 
function_index 0.006 0.001 5.050 0.000 
chronic_index 0.032 0.015 2.170 0.031 
diabetes 0.174 0.029 5.930 0.000 
heart 0.386 0.035 11.020 0.000 
asthma 0.121 0.046 2.630 0.009 
arthritis 0.068 0.029 2.390 0.017 
High blood pressure 0.122 0.027 4.470 0.000 
stroke 0.128 0.037 3.430 0.001 
married -0.014 0.023 -0.630 0.529 
less than high school -0.125 0.029 -4.240 0.000 
college and graduate 0.097 0.028 3.450 0.001 
other degree 0.083 0.045 1.830 0.069 
poor or near poor -0.032 0.037 -0.880 0.378 
middle income 0.014 0.035 0.400 0.691 
high income 0.100 0.036 2.770 0.006 
medicaid 0.171 0.042 4.040 0.000 
private hmo 0.091 0.034 2.650 0.008 
private non-hmo 0.179 0.026 6.880 0.000 
exercise -0.057 0.024 -2.390 0.017 
    Continued 
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Explanatory Variables β SE t P > t 
smoker -0.120 0.038 -3.140 0.002 
insurance not needed -0.217 0.050 -4.320 0.000 
insurance not worth the cost -0.217 0.025 -8.780 0.000 
northeast 0.082 0.029 2.820 0.005 
midwest 0.136 0.031 4.350 0.000 
south 0.022 0.026 0.860 0.391 
metropolitan area 0.087 0.025 3.530 0.000 
english language 0.036 0.073 0.490 0.624 
intercept 9.375 0.197 47.510 0.000 
Source: Data are from the household component files of the 2002-2009 MEPS.  
Note: Estimates are for near-elderly non-Medicare beneficiaries ages 55-63 and Medicare 
beneficiaries ages 65 and older, who self-report being White, African-American, or Hispanic 
with a positive drug expenditure.  
n=34840, Wald-test of null that all parameters are 0: : F( 44,   412) = 104.60  p < .0001 
Boxcox-test to find the appropriate link function: θ=0.089, SE=0.003, CI=0.084-0.094 
Modified Park-test to find the appropriate distribution family: λ=1.774, 
SE=0.090, CI=1.598-1.950 
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This dissertation seeks to evaluate whether Medicare Part D has reduced racial/ethnic 
disparities in prescription drug utilization and spending among Medicare seniors.  Using 
nationally representative data on White, African-American, and Hispanic Medicare seniors from 
the 2002-2009 Medical Expenditure Panel Survey, this dissertation analyzes eight measures of 
access and utilization related to prescription medications.  This dissertation applies the Institute 
of Medicine’s definition of a racial/ethnic disparity, and adopts a difference-in-differences quasi-
experimental design, using a multivariate regression framework.  It finds strong evidence that 
Medicare Part D reduced ethnic disparities in prescription drug use, total prescription drug cost, 
out-of-pocket prescription drug cost, and prevalence of any emergency department visits 
between White and Hispanic seniors.  However, it has little effect on disparities between White 
and African-American seniors.  This dissertation finds that there still exist significant 
racial/ethnic disparities between White and minority seniors in prescription drugs utilization and 
spending.   
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